<!DOCTYPE article PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Publishing DTD v1.1 20151215//EN" "https://jats.nlm.nih.gov/publishing/1.1/JATS-journalpublishing1.dtd">
<article xmlns:xlink="http://www.w3.org/1999/xlink" specific-use="sps-1.9" dtd-version="1.1" xml:lang="pt" article-type="letter">
  <front>
    <journal-meta>
      <journal-id journal-id-type="publisher-id">abc</journal-id>
      <journal-title-group>
        <journal-title>Arquivos Brasileiros de Cardiologia</journal-title>
        <abbrev-journal-title abbrev-type="publisher">Arq. Bras. Cardiol.</abbrev-journal-title>
      </journal-title-group>
      <issn pub-type="ppub">0066-782X</issn>
      <issn pub-type="epub">1678-4170</issn>
      <publisher>
        <publisher-name>Sociedade Brasileira de Cardiologia - SBC</publisher-name>
        <publisher-loc>S&#227;o Paulo, SP, Brazil</publisher-loc>
      </publisher>
    </journal-meta>
    <article-meta>
      <article-id pub-id-type="publisher-id" specific-use="scielo-v3">vjV7yYPWw6CYGKbMKhjfpFM</article-id>
      <article-id pub-id-type="other">00004</article-id>
      <article-id pub-id-type="publisher-id" specific-use="scielo-v2">S0066-782X2011000500004</article-id>
      <article-id pub-id-type="publisher-id" specific-use="scielo-v1">S0066-782X(11)09600504</article-id>
      <article-id pub-id-type="doi">10.1590/S0066-782X2011005000044</article-id>
      <article-categories>
        <subj-group subj-group-type="heading">
          <subject>Artigos Originais</subject>
        </subj-group>
      </article-categories>
      <title-group>
        <article-title>Rela&#231;&#227;o entre imagem adren&#233;rgica card&#237;aca e teste ergom&#233;trico na insufici&#234;ncia card&#237;aca</article-title>
      </title-group>
      <contrib-group>
        <contrib contrib-type="author">
          <name>
            <surname>Messias</surname>
            <given-names>Leandro Rocha</given-names>
          </name>
          <xref ref-type="aff" rid="aff01"/>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Carreira</surname>
            <given-names>Maria &#194;ngela M. de Queiroz</given-names>
          </name>
          <xref ref-type="aff" rid="aff01"/>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Miranda</surname>
            <given-names>Sandra Marina Ribeiro de</given-names>
          </name>
          <xref ref-type="aff" rid="aff01"/>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Azevedo</surname>
            <given-names>Jader Cunha de</given-names>
          </name>
          <xref ref-type="aff" rid="aff01"/>
          <xref ref-type="aff" rid="aff02"/>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Gava</surname>
            <given-names>Isabela Ambr&#243;sio</given-names>
          </name>
          <xref ref-type="aff" rid="aff01"/>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Rodrigues</surname>
            <given-names>Ronaldo Campos</given-names>
          </name>
          <xref ref-type="aff" rid="aff01"/>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Mar&#243;stica</surname>
            <given-names>Elizabeth</given-names>
          </name>
          <xref ref-type="aff" rid="aff01"/>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>N&#243;brega</surname>
            <given-names>Ant&#244;nio Claudio Lucas da</given-names>
          </name>
          <xref ref-type="aff" rid="aff01"/>
          <xref ref-type="aff" rid="aff02"/>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Mesquita</surname>
            <given-names>Claudio Tinoco</given-names>
          </name>
          <xref ref-type="aff" rid="aff01"/>
          <xref ref-type="aff" rid="aff02"/>
        </contrib>
      </contrib-group>
      <aff id="aff01">
        <addr-line>
          <named-content content-type="city">Niter&#243;i</named-content>
          <named-content content-type="state">Rio de Janeiro</named-content>
        </addr-line>
        <institution content-type="orgname">Universidade Federal Fluminense</institution>
        <country country="BR">Brazil</country>
      </aff>
      <aff id="aff02">
        <addr-line>
          <named-content content-type="city">Rio de Janeiro</named-content>
          <named-content content-type="state"/>
        </addr-line>
        <institution content-type="orgname">Hospital Pr&#243;-Card&#237;aco</institution>
        <country country="BR">Brazil</country>
      </aff>
      <pub-date date-type="collection" publication-format="electronic">
        <month>05</month>
        <year>2011</year>
      </pub-date>
      <volume>96</volume>
      <issue>5</issue>
      <fpage>370</fpage>
      <lpage>376</lpage>
      <history>
        <date date-type="rev-recd">
          <day>09</day>
          <month>11</month>
          <year>2010</year>
        </date>
        <date date-type="received">
          <day>22</day>
          <month>08</month>
          <year>2010</year>
        </date>
        <date date-type="accepted">
          <day>20</day>
          <month>12</month>
          <year>2010</year>
        </date>
      </history>
      <permissions>
        <license license-type="open-access" xlink:href="http://creativecommons.org/licenses/by-nc/4.0/" xml:lang="en">
          <license-p>This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.</license-p>
        </license>
      </permissions>
      <abstract>
        <p>FUNDAMENTO: Na insufici&#234;ncia card&#237;aca, o teste ergom&#233;trico (TE) avalia capacidade funcional, um determinante de progn&#243;stico. A cintilografia com I&#185;&#178;&#179; MIBG mostra a ativa&#231;&#227;o simp&#225;tica card&#237;aca. OBJETIVO: Avaliar a associa&#231;&#227;o entre as vari&#225;veis do TE e as altera&#231;&#245;es da cintilografia com I&#185;&#178;&#179; MIBG. M&#201;TODOS: Foram submetidos 23 pacientes (FEVE &lt; 45%) &#224; cintilografia com I&#185;&#178;&#179; MIBG e separados em: G1) taxa de Washout &lt; 27%; G2) &gt; 27%. Esses pacientes realizaram TE, onde foram analisadas: press&#227;o arterial sist&#243;lica no pico do esfor&#231;o (PASP), frequ&#234;ncia card&#237;aca no pico do esfor&#231;o (FCP), varia&#231;&#227;o da press&#227;o arterial sist&#243;lica intraesfor&#231;o (&#916; PAS), reserva cronotr&#243;pica e capacidade funcional em METs. Utilizaram-se para a an&#225;lise estat&#237;stica, o teste t de Student ou o teste U de Mann-Whitney, o coeficiente de Spearman e o coeficiente de regress&#227;o linear. RESULTADOS: A PASP (G1: 181,00 &#177; 28,01; G2: 153,27 &#177; 27,71, p = 0,027), a &#916; PAS [G1: 64 (47,5-80,5); G2: 36 (25-47) mmHg, p = 0,015], a FCP (G1: 136,91 &#177; 19,66; G2: 118,45 &#177; 13,98 bpm, p = 0,018), a reserva cronotr&#243;pica (G1: 70,42 &#177; 17,94; G2: 49,47 &#177; 14,89%, p = 0,006) e a capacidade funcional [G1: 8,37 (6,47-10,27); G2: 4,42 (2,46-6,38) METs, p = 0,003] foram menores no G2. Houve correla&#231;&#227;o negativa entre taxa de Washout com PASP (r = -0,505, p = 0,014), &#916; PAS (r = -0,493, p = 0,017) e capacidade funcional (r = -0,646, p = 0,001). Ap&#243;s regress&#227;o linear, PASP (r = -0,422, p = 0,016) e capacidade funcional (r = -0,804, p = 0,004) foram associadas com taxa de Washout. CONCLUS&#195;O: Em pacientes com insufici&#234;ncia card&#237;aca, PASP e capacidade funcional foram as var&#225;veis mais associadas com a taxa de Washout.</p>
      </abstract>
      <kwd-group xml:lang="pt" kwd-group-type="author-generated">
        <kwd>MIBG</kwd>
        <kwd>teste de esfor&#231;o</kwd>
        <kwd>insufici&#234;ncia card&#237;aca</kwd>
      </kwd-group>
      <pub-date publication-format="electronic" date-type="pub">
        <day>15</day>
        <month>04</month>
        <year>2011</year>
      </pub-date>
    </article-meta>
  </front>
  <body>
    <p>
      <bold>ARTIGO ORIGINAL</bold>
    </p>
    <p>Rela&#231;&#227;o entre imagem adren&#233;rgica card&#237;aca e teste ergom&#233;trico na insufici&#234;ncia card&#237;aca</p>
    <p>
      <bold>Leandro Rocha Messias<sup>I</sup>; Maria &#194;ngela M. de Queiroz Carreira<sup>I</sup>; Sandra Marina Ribeiro de Miranda<sup>I</sup>; Jader Cunha de Azevedo<sup>I,II</sup>; Isabela Ambr&#243;sio Gava<sup>I</sup>; Ronaldo Campos Rodrigues<sup>I</sup>; Elizabeth Mar&#243;stica<sup>I</sup>; Ant&#244;nio Claudio Lucas da N&#243;brega<sup>I,II</sup>; Claudio Tinoco Mesquita<sup>I,II</sup></bold>
    </p>
    <p><sup>I</sup>Universidade Federal Fluminense, Niter&#243;i, RJ </p>
    <p><sup>II</sup>Hospital Procard&#237;aco, Rio de Janeiro, RJ - Brasil</p>
    <p>
      <xref ref-type="corresp" rid="end">Correspond&#234;ncia</xref>
    </p>
    <p>
      <bold>RESUMO</bold>
    </p>
    <p><bold>FUNDAMENTO:</bold> Na insufici&#234;ncia card&#237;aca, o teste ergom&#233;trico (TE) avalia capacidade funcional, um determinante de progn&#243;stico. A cintilografia com I&#185;&#178;&#179; MIBG mostra a ativa&#231;&#227;o simp&#225;tica card&#237;aca. </p>
    <p><bold>OBJETIVO:</bold> Avaliar a associa&#231;&#227;o entre as vari&#225;veis do TE e as altera&#231;&#245;es da cintilografia com I&#185;&#178;&#179; MIBG. </p>
    <p><bold>M&#201;TODOS:</bold> Foram submetidos 23 pacientes (FEVE <underline>&lt;</underline> 45%) &#224; cintilografia com I&#185;&#178;&#179; MIBG e separados em: G1) taxa de <italic>Washout</italic> &lt; 27%; G2) <underline>&gt;</underline> 27%. Esses pacientes realizaram TE, onde foram analisadas: press&#227;o arterial sist&#243;lica no pico do esfor&#231;o (PASP), frequ&#234;ncia card&#237;aca no pico do esfor&#231;o (FCP), varia&#231;&#227;o da press&#227;o arterial sist&#243;lica intraesfor&#231;o (&#916; PAS), reserva cronotr&#243;pica e capacidade funcional em METs. Utilizaram-se para a an&#225;lise estat&#237;stica, o teste <italic>t</italic> de <italic>Student</italic> ou o teste U de <italic>Mann-Whitney</italic>, o coeficiente de <italic>Spearman </italic>e o coeficiente de regress&#227;o linear. </p>
    <p><bold>RESULTADOS:</bold> A PASP (G1: 181,00 &#177; 28,01; G2: 153,27 &#177; 27,71, p = 0,027), a &#916; PAS [G1: 64 (47,5-80,5); G2: 36 (25-47) mmHg, p = 0,015], a FCP (G1: 136,91 &#177; 19,66; G2: 118,45 &#177; 13,98 bpm, p = 0,018), a reserva cronotr&#243;pica (G1: 70,42 &#177; 17,94; G2: 49,47 &#177; 14,89%, p = 0,006) e a capacidade funcional [G1: 8,37 (6,47-10,27); G2: 4,42 (2,46-6,38) METs, p = 0,003] foram menores no G2. Houve correla&#231;&#227;o negativa entre taxa de <italic>Washout</italic> com PASP (r = -0,505, p = 0,014), &#916; PAS (r = -0,493, p = 0,017) e capacidade funcional (r = -0,646, p = 0,001). Ap&#243;s regress&#227;o linear, PASP (r = -0,422, p = 0,016) e capacidade funcional (r = -0,804, p = 0,004) foram associadas com taxa de <italic>Washout</italic>. </p>
    <p><bold>CONCLUS&#195;O:</bold> Em pacientes com insufici&#234;ncia card&#237;aca, PASP e capacidade funcional foram as var&#225;veis mais associadas com a taxa de <italic>Washout</italic>.</p>
    <p><bold>Palavras-chave:</bold> MIBG, teste de esfor&#231;o, insufici&#234;ncia card&#237;aca.</p>
    <p>
      <bold>Introdu&#231;&#227;o</bold>
    </p>
    <p>Na insufici&#234;ncia card&#237;aca (IC), o teste ergom&#233;trico (TE) &#233; indicado para avaliar capacidade funcional, presen&#231;a de sintomas e a terap&#234;utica<sup>1</sup>. Alguns dos par&#226;metros empregados no TE s&#227;o o comportamento da press&#227;o arterial sist&#243;lica (PAS) intraesfor&#231;o e a reserva cronotr&#243;pica, que s&#227;o reconhecidos preditores de progn&#243;stico<sup>2-4</sup>. A hiperatividade adren&#233;rgica, caracter&#237;stica da IC, pode levar &#224; incompet&#234;ncia cronotr&#243;pica, &#224; queda da resposta contr&#225;til card&#237;aca &#224;s catecolaminas e &#224; diminui&#231;&#227;o da reserva simp&#225;tica durante o exerc&#237;cio. Uma inadequada resposta da PAS e da frequ&#234;ncia card&#237;aca (FC) tem sido associada a um risco duas vezes maior de mortalidade e eventos cardiovasculares adversos<sup>2,5-7</sup>. Tanto para a popula&#231;&#227;o geral<sup>8</sup>, quanto na popula&#231;&#227;o com IC<sup>2,9</sup>, a capacidade funcional &#233; um importante preditor de progn&#243;stico e n&#227;o est&#225; relacionada com medidas da fun&#231;&#227;o ventricular em repouso e tampouco com a fra&#231;&#227;o de eje&#231;&#227;o ventricular esquerda<sup>10</sup>.</p>
    <p>A atividade e a inerva&#231;&#227;o simp&#225;tica card&#237;aca podem ser avaliadas pela cintilografia com metaiodobenzilguanidina marcada com iodo 123 (I<sup>123</sup> MIBG)<sup>11-13</sup>. Estudos demonstraram<sup>13-16</sup> que a imagem precoce representa a integridade dos terminais nervosos pr&#233;-sin&#225;pticos e a densidade dos betarreceptores. A capta&#231;&#227;o neuronal pr&#233;-sin&#225;ptica contribui para a imagem tardia, combinando informa&#231;&#245;es da fun&#231;&#227;o neural, incluindo capta&#231;&#227;o, libera&#231;&#227;o e estocagem da noradrenalina nas ves&#237;culas pr&#233;-sin&#225;pticas. A taxa de <italic>Washout</italic> &#233; um par&#226;metro que avalia o grau de atividade simp&#225;tica. Pacientes com IC podem apresentar: (1) reduzida capta&#231;&#227;o do tra&#231;ador devido &#224; perda de neur&#244;nios simp&#225;ticos e/ou dist&#250;rbios na capta&#231;&#227;o prim&#225;ria de noradrenalina; e (2) aumento da taxa de <italic>Washout</italic>, refletindo o transbordamento de noradrenalina para a corrente sangu&#237;nea<sup>11,14,17-19</sup>. Taxa de <italic>Washout</italic> menor que 27% &#233; descritor de forte preditor de sobrevida<sup>20</sup>.</p>
    <p>At&#233; o momento, n&#227;o h&#225; evid&#234;ncias se a hiperativa&#231;&#227;o adren&#233;rgica em repouso se associa com altera&#231;&#245;es hemodin&#226;micas no exerc&#237;cio, ou se as vari&#225;veis do TE se associam com as vari&#225;veis da cintilografia. Portanto, o objetivo deste estudo &#233; avaliar se as vari&#225;veis do TE convencional na IC podem detectar pacientes que apresentam disfun&#231;&#227;o simp&#225;tica na cintilografia com I<sup>123 </sup>MIBG. Esses achados poderiam permitir a avalia&#231;&#227;o do risco com uma t&#233;cnica mais dispon&#237;vel no nosso meio, selecionando os pacientes com maior probabilidade de apresentarem altera&#231;&#245;es &#224; cintilografia.</p>
    <p>
      <bold>M&#233;todos</bold>
    </p>
    <p>Foram selecionados 23 pacientes consecutivos atendidos no ambulat&#243;rio especializado em IC do Hospital Universit&#225;rio Ant&#244;nio Pedro, da Universidade Federal Fluminense. Os pacientes selecionados apresentavam IC e fra&#231;&#227;o de eje&#231;&#227;o ventricular esquerda menor ou igual a 45%, mensurada atrav&#233;s da ecocardiografia, pela t&#233;cnica de Simpson. Foram exclu&#237;dos do estudo os pacientes que apresentavam: fibrila&#231;&#227;o atrial, diab&#233;ticos, portadores de dispositivo de estimula&#231;&#227;o ventricular, endocrinopatias, doen&#231;a de Parkinson, mulheres gr&#225;vidas ou em per&#237;odo de amamenta&#231;&#227;o. N&#227;o foi suspensa nenhuma medica&#231;&#227;o para realiza&#231;&#227;o do estudo e todos se encontravam em tratamento com doses otimizadas dos medicamentos padr&#227;o para IC, incluindo o uso de betabloqueador (carvedilol). Os volunt&#225;rios assinaram um termo de consentimento livre e esclarecido concordando em fazer parte do projeto. O projeto foi aprovado pelo comit&#234; de &#233;tica em pesquisa do Hospital Universit&#225;rio Ant&#244;nio Pedro, sob o n&#250;mero 011/09. </p>
    <p>Os pacientes realizaram TE sintoma-limitado (<italic>software </italic>ErgoPC 13 vers&#227;o 2.2) em esteira, marca Imbramed, devidamente calibrada conforme orienta&#231;&#245;es do fabricante, em protocolo de Rampa. Foram avaliados o comportamento da press&#227;o arterial sist&#243;lica (PAS), da frequ&#234;ncia card&#237;aca (FC) intraesfor&#231;o e a capacidade funcional. A medida da press&#227;o arterial foi realizada por m&#233;todo indireto com utiliza&#231;&#227;o de esfigmoman&#244;metro com coluna de merc&#250;rio, devidamente calibrado, aferida no bra&#231;o esquerdo do pacientes em posi&#231;&#227;o ortost&#225;tica. A medida da frequ&#234;ncia card&#237;aca foi feita atrav&#233;s do intervalo RR do tra&#231;ado do eletrocardiograma (ECG) atrav&#233;s do pr&#243;prio <italic>software</italic>. Avaliaram-se a PAS e a FC no pico do esfor&#231;o, a varia&#231;&#227;o da PAS no pico do esfor&#231;o em rela&#231;&#227;o ao repouso (&#916; PAS), o &#237;ndice de reserva cronotr&#243;pica, atrav&#233;s da f&#243;rmula: (<italic>"{[FC no pico do esfor&#231;o - FC de repouso / (220 - Idade) - FC de repouso] x 100}")</italic><sup>4</sup>. A capacidade funcional foi estimada pelo <italic>software </italic>de acordo com a carga de trabalho alcan&#231;ada. </p>
    <p>Os pacientes realizaram a cintilografia mioc&#225;rdica com I&#185;&#178;&#179; MIBG, para avaliar a inerva&#231;&#227;o adren&#233;rgica card&#237;aca, atrav&#233;s da capta&#231;&#227;o do radiotra&#231;ador, com estudo da rela&#231;&#227;o cora&#231;&#227;o/mediastino (C/M) para as imagens precoces (30 minutos) e tardias (4 horas), al&#233;m do c&#225;lculo da taxa de <italic>Washout </italic>{<italic>[(C/M precoce - C/M tardia) / (C/M precoce)] x 100}</italic><sup>11</sup>. Todos os exames cintilogr&#225;ficos foram realizados no Servi&#231;o de Medicina Nuclear do Hospital Pr&#243;-Card&#237;aco do Rio de Janeiro, em c&#226;mara de cintila&#231;&#227;o tipo <italic>Anger</italic> tomogr&#225;fica digital (<italic>Single Photon Emission Computed Tomography</italic>) da marca <italic>Siemens</italic>, modelo <italic>E-Cam</italic> de detector duplo, com colimador de baixa energia e alta resolu&#231;&#227;o. </p>
    <p>Os pacientes foram divididos em dois grupos de acordo com a taxa de <italic>Washout</italic> (WO): Grupo 1 (G1), taxa de <italic>Washout</italic> &lt; 27% (normal); Grupo 2 (G2), taxa de <italic>Washout</italic> <underline>&gt;</underline> 27% (alterado)<sup>21</sup>. Para a an&#225;lise estat&#237;stica, foi utilizado o <italic>software</italic> SPSS vers&#227;o 15. Para avalia&#231;&#227;o das vari&#225;veis qualitativas, foi utilizado o teste qui-quadrado. Para avalia&#231;&#227;o das vari&#225;veis quantitativas foi utilizado o teste <italic>t</italic> de <italic>Student</italic> ou teste <italic>U</italic> de <italic>Mann-Withney</italic>, conforme a distribui&#231;&#227;o dos dados. Foi utilizado o coeficiente de correla&#231;&#227;o de <italic>Spearman</italic> para avaliar a correla&#231;&#227;o das vari&#225;veis do exerc&#237;cio com a WO. Empregamos a regress&#227;o linear <italic>stepwise </italic>para identificar as vari&#225;veis associadas com hipertonia simp&#225;tica avaliada pela taxa de <italic>Washout</italic>. Foi considerado com signific&#226;ncia estat&#237;stica o valor de p &lt; 0,05.</p>
    <p>
      <bold>Resultados</bold>
    </p>
    <p>As caracter&#237;sticas dos pacientes s&#227;o mostradas na <xref ref-type="table" rid="tab01">Tabela 1</xref>. N&#227;o houve diferen&#231;as significativas na idade, sexo, &#237;ndice de massa corporal, etiologia da IC, fra&#231;&#227;o de eje&#231;&#227;o ventricular esquerda, uso de medica&#231;&#245;es e dose do carvedilol, entre os grupos.</p>
    <table-wrap id="tab01">
      <graphic xlink:href="1678-4170-abc-96-05-0370-00044-gt01.jpg"/></table-wrap>
    <p>Os grupos se mostraram semelhantes em repouso. No pico de esfor&#231;o, houve diferen&#231;a significativa entre o G1 e o G2, sendo que este &#250;ltimo apresentou menores valores absolutos de PAS e da FC, menor varia&#231;&#227;o da PAS intraesfor&#231;o, menor &#237;ndice de reserva cronotr&#243;pica e uma menor capacidade funcional. Os par&#226;metros do exerc&#237;cio s&#227;o mostrados na <xref ref-type="table" rid="tab02">Tabela 2</xref>, e a <xref ref-type="fig" rid="fig01">Figura 1</xref> apresenta as diferen&#231;as no comportamento da PAS durante o esfor&#231;o.</p>
    <table-wrap id="tab02">
      <graphic xlink:href="1678-4170-abc-96-05-0370-00044-gt02.jpg"/></table-wrap>
    <fig id="fig01">
      <graphic xlink:href="1678-4170-abc-96-05-0370-00044-gf01.jpg"/></fig>
    <p>Apesar de divididos pela taxa de <italic>Washout</italic>, n&#227;o houve diferen&#231;a significativa na rela&#231;&#227;o C/M precoce de I<sup>123</sup> MIBG (G1: 1,78 &#177; 0,25 <italic>vs</italic> G2: 1,74 &#177; 0,22; p = 0,710) e na rela&#231;&#227;o C/M tardia (G1: 1,74 &#177; 0,20 <italic>vs</italic> G2: 1,60 &#177; 0,22; p = 0,129). A <xref ref-type="fig" rid="fig02">Figura 2</xref> ilustra a imagem card&#237;aca com I<sup>123 </sup>MIBG de um paciente com IC que apresenta par&#226;metros de exerc&#237;cio normais (capacidade funcional de 8,23 METs, varia&#231;&#227;o da PAS intraesfor&#231;o de 65 mmHg e &#237;ndice de reserva cronotr&#243;pica de 68%). A capta&#231;&#227;o do MIBG foi normal e a taxa de <italic>Washout</italic> foi de 21%.</p>
    <fig id="fig02">
      <graphic xlink:href="1678-4170-abc-96-05-0370-00044-gf02.jpg"/></fig>
    <p>Quando analisamos a correla&#231;&#227;o entre as vari&#225;veis do exerc&#237;cio e a taxa de <italic>Washout</italic>, observamos uma significativa correla&#231;&#227;o negativa entre a taxa de <italic>Washout</italic> e as seguintes vari&#225;veis: PAS no pico do esfor&#231;o, varia&#231;&#227;o da PAS intraesfor&#231;o e a capacidade funcional (<xref ref-type="table" rid="tab03">Tabela 3</xref>). N&#227;o foi observada signific&#226;ncia estat&#237;stica na correla&#231;&#227;o com a FC no pico do esfor&#231;o e do &#237;ndice de reserva cronotr&#243;pica com WO (<xref ref-type="table" rid="tab03">Tabela 3</xref>).</p>
    <table-wrap id="tab03">
      <graphic xlink:href="1678-4170-abc-96-05-0370-00044-gt03.jpg"/></table-wrap>
    <p>Ap&#243;s regress&#227;o linear stepwise, as vari&#225;veis associadas com disautonomia pela taxa de <italic>Washout</italic> foram: a PAS no pico do esfor&#231;o (r = -0,422; p = 0,016) e a capacidade funcional em METs (r = -0,804; p = 0,004).</p>
    <p>
      <bold>Discuss&#227;o</bold>
    </p>
    <p>Em nosso estudo, observamos que em pacientes com IC a PAS no pico do esfor&#231;o e a capacidade funcional, medida atrav&#233;s do n&#250;mero de METs atingido, est&#227;o associadas a altera&#231;&#245;es na inerva&#231;&#227;o adren&#233;rgica card&#237;aca, conforme evidenciado pela taxa de <italic>Washout</italic> obtida atrav&#233;s da cintilografia mioc&#225;rdica com I<sup>123</sup> MIBG. Durante o TE, nos pacientes com taxa de <italic>Washout</italic> alterada (estado de hipertonia adren&#233;rgica em repouso), verificamos que a PAS no pico do esfor&#231;o e o n&#250;mero de METs apresentaram menores valores quando comparados com os dos pacientes com taxa de <italic>Washout</italic> normal. N&#227;o h&#225;, at&#233; o presente momento, descri&#231;&#227;o na literatura dessa associa&#231;&#227;o entre tal comportamento anormal da PAS e altera&#231;&#245;es na inerva&#231;&#227;o adren&#233;rgica card&#237;aca pelo I<sup>123</sup> MIBG.</p>
    <p>A varia&#231;&#227;o da PAS durante o exerc&#237;cio associa-se diretamente com o d&#233;bito card&#237;aco durante o esfor&#231;o: uma menor eleva&#231;&#227;o da PAS intraesfor&#231;o pode ser resultado de d&#233;ficit inotr&#243;pico durante o exerc&#237;cio, que &#233; um fen&#244;meno comum em pacientes com disfun&#231;&#227;o ventricular, sendo este achado associado com pior progn&#243;stico<sup>2</sup>. Fargard e cols.<sup>22</sup>, em uma amostra de pacientes candidatos a transplante card&#237;aco, demonstraram que uma varia&#231;&#227;o inadequada da PAS em resposta ao exerc&#237;cio subm&#225;ximo &#233; preditora de eventos card&#237;acos. </p>
    <p>Willians e cols.<sup>23</sup> avaliaram pacientes com IC de diferentes classes funcionais, demonstrando que simples par&#226;metros obtidos no teste, como a dura&#231;&#227;o e a PAS no pico do esfor&#231;o, s&#227;o fortes preditores de progn&#243;stico atrav&#233;s de an&#225;lise multivariada, superando a fra&#231;&#227;o de eje&#231;&#227;o ventricular esquerda e fra&#231;&#227;o N terminal proBNP (NT-proBNP). </p>
    <p>Nishiyama e cols.<sup>2</sup> avaliaram a resposta da PAS durante o exerc&#237;cio como preditor de progn&#243;stico em pacientes com IC. Por an&#225;lise univariada, PAS e FC no pico do esfor&#231;o, al&#233;m de suas varia&#231;&#245;es durante o exerc&#237;cio (&#916; PAS/&#916; FC = pico do esfor&#231;o - repouso) foram preditores de mortalidade. Nesse estudo, o grupo n&#227;o sobrevivente apresentou menores valores de tais vari&#225;veis. Ap&#243;s an&#225;lise multivariada, o &#916; PAS e a capacidade funcional, obtida atrav&#233;s do n&#250;mero de METs atingido, foram os melhores preditores de mortalidade, independente do uso de betabloqueador. </p>
    <p>O consumo de oxig&#234;nio (VO<sub>2</sub>) m&#225;ximo &#233; um par&#226;metro utilizado para avaliar, em pacientes com IC, candidatos ao transplante card&#237;aco<sup>24</sup>, sendo tamb&#233;m um poderoso preditor de progn&#243;stico<sup>24-26</sup>. Willens e cols.<sup>27</sup>, estudando 40 pacientes com IC, classe funcional II e III da <italic>New York Heart Association </italic>(NYHA), demonstraram que o VO<sub>2</sub> m&#225;ximo, tanto por medida indireta (de acordo com o tempo do exerc&#237;cio), quanto por medida direta, atrav&#233;s do Teste Cardiopulmonar do Exerc&#237;cio, &#233; um importante preditor de sobrevida, promovendo informa&#231;&#245;es &#250;teis para o acompanhamento dos pacientes. Outra forma de avaliar o VO<sub>2</sub> m&#225;ximo por medida indireta &#233; atrav&#233;s do n&#250;mero de METs atingido no TE<sup>2</sup>.</p>
    <p>Em um estudo envolvendo indiv&#237;duos saud&#225;veis, Snader e cols.<sup>8</sup> demonstraram que a capacidade funcional foi um poderoso preditor de mortalidade cardiovascular. Nesse trabalho, a taxa de mortalidade cardiovascular foi maior no grupo que n&#227;o conseguiu alcan&#231;ar 06 METs no TE, e sua associa&#231;&#227;o com defeitos diagnosticados na perfus&#227;o pela cintilografia mioc&#225;rdica com t&#225;lio, colocou esses pacientes em um patamar de risco ainda maior para eventos adversos.</p>
    <p>Jeng e cols.<sup>28</sup> avaliaram a influ&#234;ncia da toler&#226;ncia ao exerc&#237;cio sobre a qualidade de vida em pacientes com IC. Os pacientes que obtiveram uma capacidade funcional maior ou igual a 05 METs, ou um tempo de TE maior ou igual 180 segundos, apresentavam uma melhor qualidade de vida, mostrando que o TE &#233; seguro, dispon&#237;vel e efetivo para avaliar a toler&#226;ncia ao exerc&#237;cio nesta popula&#231;&#227;o. Rubim e cols.<sup>29</sup> demonstraram que o n&#250;mero de METs atingido no TE correlaciona-se significativamente com a mortalidade. </p>
    <p>Myers e cols.<sup>30</sup>, avaliando escores de qualidade de vida, teste da caminhada dos 06 minutos e n&#250;meros de METs atingido no TE em pacientes com IC, e correlacionando essas vari&#225;veis com VO<sub>2</sub> m&#225;ximo obtido atrav&#233;s do Teste Cardiopulmonar do Exerc&#237;cio, conclu&#237;ram que ambos refletem, &#224; sua maneira, o estado cl&#237;nico do paciente e t&#234;m sua import&#226;ncia nesse contexto cl&#237;nico, sem, no entanto, um substituir o outro. Quando comparado com a dist&#226;ncia percorrida no teste da caminhada dos 06 minutos, a capacidade funcional determinada pelo n&#250;mero de METs no TE correlacionou-se significativamente melhor com o VO<sub>2</sub> m&#225;ximo obtido por medida direta. </p>
    <p>Chandrashekhar e cols.<sup>31</sup> analisaram a capacidade das vari&#225;veis comumente empregadas no TE em predizer o VO<sub>2</sub> m&#225;ximo. Ap&#243;s an&#225;lise de regress&#227;o <italic>stepwise,</italic> o melhor preditor do VO<sub>2</sub> m&#225;ximo foi o n&#250;mero de METs alcan&#231;ado. Apesar dos autores afirmarem que o n&#250;mero de METs n&#227;o tenha uma precis&#227;o elevada, mesmo assim ainda &#233; melhor preditor cl&#237;nico que as outras vari&#225;veis obtidas, como por exemplo, o comportamento da FC durante o esfor&#231;o. </p>
    <p>Uma das mais significativas modifica&#231;&#245;es no tratamento da insufici&#234;ncia card&#237;aca foi &#224; introdu&#231;&#227;o dos betabloqueadores. Parikh e cols.<sup>32</sup>, em pacientes com IC, classe funcional do NYHA III e IV, avaliaram o efeito do betabloqueador metoprolol sobre o n&#250;mero de METs atingido no TE, concluindo que a otimiza&#231;&#227;o do betabloqueador melhora o desempenho no exerc&#237;cio, avaliado tanto pelo tempo de exerc&#237;cio, quanto pelo n&#250;mero de METs.</p>
    <p>Alguns estudos sugerem que a melhora, que n&#227;o &#233; universalmente observada, pode ser, em parte, decorrente da melhora da fun&#231;&#227;o endotelial, devido ao uso dos betabloqueadores associado com inibidor da enzima conversora de angiotensina<sup>33</sup>. </p>
    <p>Outra vertente de marcadores de risco na IC &#233; atrav&#233;s da imagem neuronal. A cintilografia com I<sup>123 </sup>MIBG tem sido validada como uma marcadora de progn&#243;stico, conforme metan&#225;lise com 1.755 pacientes, publicada por Verbene e cols.<sup>19</sup>, que demonstrou que uma redu&#231;&#227;o da rela&#231;&#227;o C/M na imagem tardia ou aumento da taxa de <italic>Washout</italic> na cintilografia mioc&#225;rdica com I<sup>123</sup> MIBG associa-se a pior progn&#243;stico quando comparado com pacientes que apresentam normalidade destes par&#226;metros. Em recente publica&#231;&#227;o, Jacobson e cols.<sup>34</sup>, em um estudo multic&#234;ntrico com pacientes com classe funcional II e III do NYHA e fra&#231;&#227;o de eje&#231;&#227;o ventricular esquerda menor que 35%, demonstraram que a avalia&#231;&#227;o adren&#233;rgica direta do cora&#231;&#227;o, atrav&#233;s da cintilografia mioc&#225;rdica com I<sup>123</sup> MIBG, foi preditora de maior mortalidade card&#237;aca e de eventos arr&#237;tmicos, de modo independente de fatores progn&#243;sticos conhecidos como a fra&#231;&#227;o de eje&#231;&#227;o ventricular esquerda, pept&#237;deo natriur&#233;tico cerebral e da classe funcional do NYHA. </p>
    <p>Analisando as informa&#231;&#245;es funcionais obtidas pela imagem neuronal com as do Teste Cardiopulmonar do Exerc&#237;cio, Cohen-Solal e cols.<sup>14</sup> correlacionaram o VO<sub>2</sub> m&#225;ximo com a capta&#231;&#227;o de I<sup>123</sup> MIBG e diversas outras vari&#225;veis (fra&#231;&#227;o de eje&#231;&#227;o ventricular esquerda, par&#226;metros hemodin&#226;micos, como &#237;ndice card&#237;aco e press&#227;o capilar pulmonar). Observaram uma significativa correla&#231;&#227;o entre os achados cintilogr&#225;ficos adren&#233;rgicos no I<sup>123 </sup>MIBG e o VO<sub>2</sub> m&#225;ximo no exerc&#237;cio. Analisando seus desfechos (morte cardiovascular e transplante card&#237;aco), o maior determinante do progn&#243;stico foi o VO<sub>2 </sub>m&#225;ximo. O VO<sub>2 </sub>m&#225;ximo se correlacionou melhor com a rela&#231;&#227;o C/M para imagem tardia do que com a rela&#231;&#227;o C/M para imagem precoce e com a taxa de <italic>Washout</italic>. Em contrapartida, o nosso estudo encontrou uma maior correla&#231;&#227;o da taxa de <italic>Washout</italic> com o n&#250;mero de METs atingido, e n&#227;o com a rela&#231;&#227;o C/M tardia, como no estudo de Cohen-Solal e cols.<sup>14</sup>.</p>
    <p>Entretanto, existem significativas diferen&#231;as entre os estudos: na nossa casu&#237;stica, avaliamos o VO<sub>2</sub> m&#225;ximo por medida indireta atrav&#233;s do n&#250;mero de METs atingidos, enquanto Cohen-Solal e cols<sup>14</sup> utilizaram medida direta do VO<sub>2</sub>. No estudo de Cohen-Solal e cols<sup>14</sup>, apenas 13% dos pacientes estavam em uso de betabloqueadores, enquanto no nosso todos os pacientes estavam em uso desta medica&#231;&#227;o. Os betabloqueadores t&#234;m como uma das suas a&#231;&#245;es a ressensibiliza&#231;&#227;o dos betarreceptores, o que pode influir na rela&#231;&#227;o C/M, fato que explicaria as diverg&#234;ncias dos achados<sup>5,35</sup>.</p>
    <p>
      <bold>Limita&#231;&#245;es do estudo</bold>
    </p>
    <p>A principal limita&#231;&#227;o do estudo foi o n&#250;mero reduzido de pacientes. Por&#233;m, atrav&#233;s de um estudo-piloto com 16 pacientes, foi realizado um c&#225;lculo amostral e o n&#250;mero de 23 pacientes tem um poder estat&#237;stico de 90% para identificar 50% de diferen&#231;a na capacidade funcional e um poder estat&#237;stico de 80% para identificar 50% de diferen&#231;a na PAS no pico do esfor&#231;o.</p>
    <p>Outra significativa limita&#231;&#227;o foi termos empregado da capacidade funcional pelo n&#250;mero de METs atingido, e n&#227;o o VO<sub>2</sub> m&#225;ximo calculado diretamente atrav&#233;s do Teste Cardiopulmonar do Exerc&#237;cio, pois n&#227;o disp&#250;nhamos do equipamento necess&#225;rio em nossa institui&#231;&#227;o, &#224; &#233;poca da realiza&#231;&#227;o deste estudo. Entretanto, como o TE &#233; uma ferramenta simples e amplamente presente no nosso meio, acreditamos que as informa&#231;&#245;es derivadas deste exame possam ser &#250;teis para os cardiologistas envolvidos com a pr&#225;tica cl&#237;nica de pacientes com IC, uma vez que se correlacionaram com a sofisticada an&#225;lise da inerva&#231;&#227;o card&#237;aca. Outra importante vari&#225;vel observada como significativa no nosso estudo, que foi a PAS no pico do esfor&#231;o, tamb&#233;m &#233; derivada do TE e n&#227;o requer complexas metodologias para an&#225;lise.</p>
    <p>
      <bold>Conclus&#227;o</bold>
    </p>
    <p>Os pacientes com IC e taxa de <italic>Washout</italic> alterada na cintilografia mioc&#225;rdica com I<sup>123</sup> MIBG apresentaram menor resposta inotr&#243;pica, cronotr&#243;pica e uma menor capacidade funcional. A PAS no pico do esfor&#231;o e o n&#250;mero de METs atingidos foram as vari&#225;veis do TE que mais se associaram com esta hipertonia adren&#233;rgica avaliada pela cintilografia. O TE convencional, atrav&#233;s da avalia&#231;&#227;o dessas duas vari&#225;veis, pode ser utilizado como uma forma de prever a presen&#231;a de hiperatividade adren&#233;rgica card&#237;aca em pacientes com IC.</p>
    <p>
      <bold>Agradecimento</bold>
    </p>
    <p>Agradecimento &#224; FAPERJ e ao CNPq pelo apoio dado aos projetos de pesquisa da Universidade Federal Fluminense.</p>
    <p>
      <bold>Potencial Conflito de Interesses</bold>
    </p>
    <p>Declaro n&#227;o haver conflito de interesses pertinentes.</p>
    <p>
      <bold>Fontes de Financiamento</bold>
    </p>
    <p>O presente estudo n&#227;o teve fontes de financiamento externas.</p>
    <p>
      <bold>Vincula&#231;&#227;o Acad&#234;mica</bold>
    </p>
    <p>Este artigo &#233; parte de disserta&#231;&#227;o de Mestrado de Leandro Rocha Messias pela Universidade Federal Fluminense.</p>
    <p>
      <fn id="end" fn-type="corresp">
        <p>Correspond&#234;ncia:</p>
        <p>Leandro Rocha Messias </p>
        <p> Rua Noronha Torrez&#227;o, 46 / 805 - Santa Rosa </p>
        <p> 24240-182 - Niter&#243;i, RJ - Brasil </p>
        <p> E-mail: </p>
        <p><email xlink:href="lmessias@cardiol.br">lmessias@cardiol.br</email>, </p>
        <p>
          <email xlink:href="leandromess@gmail.com">leandromess@gmail.com</email>
        </p>
      </fn>
    </p>
    <p> Artigo recebido em 22/08/10; revisado recebido em 09/11/10; aceito em 20/12/10</p>
    <p>Full texts in English - <ext-link ext-link-type="uri" xlink:href="http://www.arquivosonline.com.br">http://www.arquivosonline.com.br</ext-link></p>
  </body>
  <back>
    <ref-list>
      <ref id="B1">
        <mixed-citation>1. Meneghelo RS, Ara&#250;jo CGS, Stein     R, Mastrocolla LE, Albuquerque PF, Serra SM, et al. / Sociedade Brasileira     de Cardiologia. III Diretrizes sobre teste ergom&#233;trico. Arq Bras Cardiol.     2010;95(5 supl 1):1-26.</mixed-citation>
        <element-citation publication-type="journal">
          <article-title>III Diretrizes sobre teste ergom&#233;trico</article-title>
          <source>Arq Bras Cardiol</source>
          <date>
            <year>2010</year>
          </date>
          <fpage>1</fpage>
          <lpage>26</lpage>
          <volume>95</volume>
          <person-group person-group-type="author">
            <name>
              <surname>Meneghelo</surname>
              <given-names>RS</given-names>
            </name>
            <name>
              <surname>Ara&#250;jo</surname>
              <given-names>CGS</given-names>
            </name>
            <name>
              <surname>Stein</surname>
              <given-names>R</given-names>
            </name>
            <name>
              <surname>Mastrocolla</surname>
              <given-names>LE</given-names>
            </name>
            <name>
              <surname>Albuquerque</surname>
              <given-names>PF</given-names>
            </name>
            <name>
              <surname>Serra</surname>
              <given-names>SM</given-names>
            </name>
          </person-group>
        </element-citation>
      </ref>
      <ref id="B2">
        <mixed-citation>2. Nishiyama Y, Morita H, Harada H, Katoh     A, Adachi H, Koga Y, et al. Systolic blood pressure response to exercise     as a predictor of mortality in patients with chronic heart failure. Int Heart     J. 2010;51(2):111-5.</mixed-citation>
        <element-citation publication-type="journal">
          <article-title>Systolic blood pressure response to exercise as a predictor of mortality in patients with chronic heart failure</article-title>
          <source>Int Heart J</source>
          <date>
            <year>2010</year>
          </date>
          <fpage>111</fpage>
          <lpage>5</lpage>
          <issue>2</issue>
          <volume>51</volume>
          <person-group person-group-type="author">
            <name>
              <surname>Nishiyama</surname>
              <given-names>Y</given-names>
            </name>
            <name>
              <surname>Morita</surname>
              <given-names>H</given-names>
            </name>
            <name>
              <surname>Harada</surname>
              <given-names>H</given-names>
            </name>
            <name>
              <surname>Katoh</surname>
              <given-names>A</given-names>
            </name>
            <name>
              <surname>Adachi</surname>
              <given-names>H</given-names>
            </name>
            <name>
              <surname>Koga</surname>
              <given-names>Y</given-names>
            </name>
          </person-group>
        </element-citation>
      </ref>
      <ref id="B3">
        <mixed-citation>3.  Arena R, Myers J, Abella J, Peberdy MA,     Bensimhon D, Chase P, et al. The prognostic value of the heart rate response     during exercise and recovery in patients with heart failure: influence of     beta-blockade. Int J Cardiol. 2010;138(2):166-73.</mixed-citation>
        <element-citation publication-type="journal">
          <article-title>The prognostic value of the heart rate response during exercise and recovery in patients with heart failure: influence of beta-blockade</article-title>
          <source>Int J Cardiol</source>
          <date>
            <year>2010</year>
          </date>
          <fpage>166</fpage>
          <lpage>73</lpage>
          <issue>2</issue>
          <volume>138</volume>
          <person-group person-group-type="author">
            <name>
              <surname>Arena</surname>
              <given-names>R</given-names>
            </name>
            <name>
              <surname>Myers</surname>
              <given-names>J</given-names>
            </name>
            <name>
              <surname>Abella</surname>
              <given-names>J</given-names>
            </name>
            <name>
              <surname>Peberdy</surname>
              <given-names>MA</given-names>
            </name>
            <name>
              <surname>Bensimhon</surname>
              <given-names>D</given-names>
            </name>
            <name>
              <surname>Chase</surname>
              <given-names>P</given-names>
            </name>
          </person-group>
        </element-citation>
      </ref>
      <ref id="B4">
        <mixed-citation>4. Kallistratos MS, Dritsas A, Laoutaris     ID, Cokkinos DV. Chronotropic and neurohumoral markers for the evaluation     of functional capacity in patients with impaired left ventricular function.     Hellenic J Cardiol. 2008;49(1):26-32.</mixed-citation>
        <element-citation publication-type="journal">
          <article-title>Chronotropic and neurohumoral markers for the evaluation of functional capacity in patients with impaired left ventricular function</article-title>
          <source>Hellenic J Cardiol</source>
          <date>
            <year>2008</year>
          </date>
          <fpage>26</fpage>
          <lpage>32</lpage>
          <issue>1</issue>
          <volume>49</volume>
          <person-group person-group-type="author">
            <name>
              <surname>Kallistratos</surname>
              <given-names>MS</given-names>
            </name>
            <name>
              <surname>Dritsas</surname>
              <given-names>A</given-names>
            </name>
            <name>
              <surname>Laoutaris</surname>
              <given-names>ID</given-names>
            </name>
            <name>
              <surname>Cokkinos</surname>
              <given-names>DV</given-names>
            </name>
          </person-group>
        </element-citation>
      </ref>
      <ref id="B5">
        <mixed-citation>5.  Colucci WS, Ribeiro JP, Rocco MB, Quigg     RJ, Creager MA, Marsh JD, et al. Impaired chronotropic response to exercise     in patients with congestive heart failure: role of postysynaptic beta-adrenergic     desensitization. Circulation. 1989;80(2):314-23.</mixed-citation>
        <element-citation publication-type="journal">
          <article-title>Impaired chronotropic response to exercise in patients with congestive heart failure: role of postysynaptic beta-adrenergic desensitization</article-title>
          <source>Circulation</source>
          <date>
            <year>1989</year>
          </date>
          <fpage>314</fpage>
          <lpage>23</lpage>
          <issue>2</issue>
          <volume>80</volume>
          <person-group person-group-type="author">
            <name>
              <surname>Colucci</surname>
              <given-names>WS</given-names>
            </name>
            <name>
              <surname>Ribeiro</surname>
              <given-names>JP</given-names>
            </name>
            <name>
              <surname>Rocco</surname>
              <given-names>MB</given-names>
            </name>
            <name>
              <surname>Quigg</surname>
              <given-names>RJ</given-names>
            </name>
            <name>
              <surname>Creager</surname>
              <given-names>MA</given-names>
            </name>
            <name>
              <surname>Marsh</surname>
              <given-names>JD</given-names>
            </name>
          </person-group>
        </element-citation>
      </ref>
      <ref id="B6">
        <mixed-citation>6.  Freeman JV, Dewey FE, Hadley DM, Myers     J, Froelicher VF. Autonomic nervous system interaction with the cardiovascular     system during exercise. Prog Cardiovasc Dis. 2006;48(5):342-62.</mixed-citation>
        <element-citation publication-type="journal">
          <article-title>Autonomic nervous system interaction with the cardiovascular system during exercise</article-title>
          <source>Prog Cardiovasc Dis</source>
          <date>
            <year>2006</year>
          </date>
          <fpage>342</fpage>
          <lpage>62</lpage>
          <issue>5</issue>
          <volume>48</volume>
          <person-group person-group-type="author">
            <name>
              <surname>Freeman</surname>
              <given-names>JV</given-names>
            </name>
            <name>
              <surname>Dewey</surname>
              <given-names>FE</given-names>
            </name>
            <name>
              <surname>Hadley</surname>
              <given-names>DM</given-names>
            </name>
            <name>
              <surname>Myers</surname>
              <given-names>J</given-names>
            </name>
            <name>
              <surname>Froelicher</surname>
              <given-names>VF</given-names>
            </name>
          </person-group>
        </element-citation>
      </ref>
      <ref id="B7">
        <mixed-citation>7. Maddox TM, Ross C, Ho PM, Masoudi FA,     Magid D, Daugherty SL, et al. The prognostic importance of abnormal heart     rate recovery and chronotropic response among exercise treadmill test patients.     Am Heart J. 2008;156(4):736-44.</mixed-citation>
        <element-citation publication-type="journal">
          <article-title>The prognostic importance of abnormal heart rate recovery and chronotropic response among exercise treadmill test patients</article-title>
          <source>Am Heart J</source>
          <date>
            <year>2008</year>
          </date>
          <fpage>736</fpage>
          <lpage>44</lpage>
          <issue>4</issue>
          <volume>156</volume>
          <person-group person-group-type="author">
            <name>
              <surname>Maddox</surname>
              <given-names>TM</given-names>
            </name>
            <name>
              <surname>Ross</surname>
              <given-names>C</given-names>
            </name>
            <name>
              <surname>Ho</surname>
              <given-names>PM</given-names>
            </name>
            <name>
              <surname>Masoudi</surname>
              <given-names>FA</given-names>
            </name>
            <name>
              <surname>Magid</surname>
              <given-names>D</given-names>
            </name>
            <name>
              <surname>Daugherty</surname>
              <given-names>SL</given-names>
            </name>
          </person-group>
        </element-citation>
      </ref>
      <ref id="B8">
        <mixed-citation>8. Snader CE, Marwick TH, Pashkow FJ, Harvey     SA, Thomas JD, Lauer MS. Importance of estimated functional capacity as a     predictor of all-cause mortality among patients referred for exercise thallium     single-photon emission computed tomography: report of 3,400 patients from     a single center. J Am Coll Cardiol. 1997;30(3):641-8.</mixed-citation>
        <element-citation publication-type="journal">
          <article-title>Importance of estimated functional capacity as a predictor of all-cause mortality among patients referred for exercise thallium single-photon emission computed tomography: report of 3,400 patients from a single center</article-title>
          <source>J Am Coll Cardiol</source>
          <date>
            <year>1997</year>
          </date>
          <fpage>641</fpage>
          <lpage>8</lpage>
          <issue>3</issue>
          <volume>30</volume>
          <person-group person-group-type="author">
            <name>
              <surname>Snader</surname>
              <given-names>CE</given-names>
            </name>
            <name>
              <surname>Marwick</surname>
              <given-names>TH</given-names>
            </name>
            <name>
              <surname>Pashkow</surname>
              <given-names>FJ</given-names>
            </name>
            <name>
              <surname>Harvey</surname>
              <given-names>SA</given-names>
            </name>
            <name>
              <surname>Thomas</surname>
              <given-names>JD</given-names>
            </name>
            <name>
              <surname>Lauer</surname>
              <given-names>MS</given-names>
            </name>
          </person-group>
        </element-citation>
      </ref>
      <ref id="B9">
        <mixed-citation>9.  Guimar&#227;es GV, Silva MS, d'Avila     VM, Ferreira SM, Silva CP, Bocchi EA. VO2 pico e inclina&#231;&#227;o     VE/VCO2 na era dos betabloqueadores na insufici&#234;ncia card&#237;aca:     uma experi&#234;ncia brasileira. Arq Bras Cardiol. 2008;91(1):42-8.</mixed-citation>
        <element-citation publication-type="journal">
          <article-title>VO2 pico e inclina&#231;&#227;o VE/VCO2 na era dos betabloqueadores na insufici&#234;ncia card&#237;aca: uma experi&#234;ncia brasileira</article-title>
          <source>Arq Bras Cardiol</source>
          <date>
            <year>2008</year>
          </date>
          <fpage>42</fpage>
          <lpage>8</lpage>
          <issue>1</issue>
          <volume>91</volume>
          <person-group person-group-type="author">
            <name>
              <surname>Guimar&#227;es</surname>
              <given-names>GV</given-names>
            </name>
            <name>
              <surname>Silva</surname>
              <given-names>MS</given-names>
            </name>
            <name>
              <surname>d'Avila VM</surname>
            </name>
            <name>
              <surname>Ferreira</surname>
              <given-names>SM</given-names>
            </name>
            <name>
              <surname>Silva</surname>
              <given-names>CP</given-names>
            </name>
            <name>
              <surname>Bocchi</surname>
              <given-names>EA</given-names>
            </name>
          </person-group>
        </element-citation>
      </ref>
      <ref id="B10">
        <mixed-citation>10. Hanson P. Exercise testing and training     in patients with chronic heart failure. Med Sci Sports Exerc. 1994;26(5):527-37.</mixed-citation>
        <element-citation publication-type="journal">
          <article-title>Exercise testing and training in patients with chronic heart failure</article-title>
          <source>Med Sci Sports Exerc</source>
          <date>
            <year>1994</year>
          </date>
          <fpage>527</fpage>
          <lpage>37</lpage>
          <issue>5</issue>
          <volume>26</volume>
          <person-group person-group-type="author">
            <name>
              <surname>Hanson</surname>
              <given-names>P</given-names>
            </name>
          </person-group>
        </element-citation>
      </ref>
      <ref id="B11">
        <mixed-citation>11. Turpeinen AK, Vanninen E, Magga J, Tuomainen     P, Kuusisto J, Sipola P, et al. Cardiac sympathetic activity is associated     with inflammation and neurohumoral activation in patients with idiopathic     dilated cardiomyopathy. Clin Physiol Funct Imaging. 2009;29(6):414-9.</mixed-citation>
        <element-citation publication-type="journal">
          <article-title>Cardiac sympathetic activity is associated with inflammation and neurohumoral activation in patients with idiopathic dilated cardiomyopathy</article-title>
          <source>Clin Physiol Funct Imaging</source>
          <date>
            <year>2009</year>
          </date>
          <fpage>414</fpage>
          <lpage>9</lpage>
          <issue>6</issue>
          <volume>29</volume>
          <person-group person-group-type="author">
            <name>
              <surname>Turpeinen</surname>
              <given-names>AK</given-names>
            </name>
            <name>
              <surname>Vanninen</surname>
              <given-names>E</given-names>
            </name>
            <name>
              <surname>Magga</surname>
              <given-names>J</given-names>
            </name>
            <name>
              <surname>Tuomainen</surname>
              <given-names>P</given-names>
            </name>
            <name>
              <surname>Kuusisto</surname>
              <given-names>J</given-names>
            </name>
            <name>
              <surname>Sipola</surname>
              <given-names>P</given-names>
            </name>
          </person-group>
        </element-citation>
      </ref>
      <ref id="B12">
        <mixed-citation>12.  Giubbini R, Milan E, Bertagna F, Mut     F, Metra M, Rodella C, et al. Nuclear cardiology and heart failure. Eur J     Nucl Med Mol Imaging. 2009 Aug 12. [Epub ahead of print]</mixed-citation>
        <element-citation publication-type="journal">
          <article-title>Nuclear cardiology and heart failure</article-title>
          <source>Eur J Nucl Med Mol Imaging</source>
          <date>
            <day>12</day>
            <year>2009</year>
            <month>08</month>
          </date>
          <person-group person-group-type="author">
            <name>
              <surname>Giubbini</surname>
              <given-names>R</given-names>
            </name>
            <name>
              <surname>Milan</surname>
              <given-names>E</given-names>
            </name>
            <name>
              <surname>Bertagna</surname>
              <given-names>F</given-names>
            </name>
            <name>
              <surname>Mut</surname>
              <given-names>F</given-names>
            </name>
            <name>
              <surname>Metra</surname>
              <given-names>M</given-names>
            </name>
            <name>
              <surname>Rodella</surname>
              <given-names>C</given-names>
            </name>
          </person-group>
        </element-citation>
      </ref>
      <ref id="B13">
        <mixed-citation>13. Agostini D, Carrio I, Verberne HJ. How     to use myocardial 123I-MIBG scintigraphy in chronic heart failure. Eur J     Nucl Med Mol Imaging. 2009;36(4):555-9.</mixed-citation>
        <element-citation publication-type="journal">
          <article-title>How to use myocardial 123I-MIBG scintigraphy in chronic heart failure</article-title>
          <source>Eur J Nucl Med Mol Imaging</source>
          <date>
            <year>2009</year>
          </date>
          <fpage>555</fpage>
          <lpage>9</lpage>
          <issue>4</issue>
          <volume>36</volume>
          <person-group person-group-type="author">
            <name>
              <surname>Agostini</surname>
              <given-names>D</given-names>
            </name>
            <name>
              <surname>Carrio</surname>
              <given-names>I</given-names>
            </name>
            <name>
              <surname>Verberne</surname>
              <given-names>HJ</given-names>
            </name>
          </person-group>
        </element-citation>
      </ref>
      <ref id="B14">
        <mixed-citation>14. Cohen-Solal A, Esanu Y, Logeart D, Pessione     F, Dubois C, Dreyfus G, et al. Cardiac metaiodobenzylguanidine uptake in     patients with moderate chronic heart failure: relationship with peak oxygen     uptake and prognosis. J Am Coll Cardiol. 1999;33(3):759-66.</mixed-citation>
        <element-citation publication-type="journal">
          <article-title>Cardiac metaiodobenzylguanidine uptake in patients with moderate chronic heart failure: relationship with peak oxygen uptake and prognosis</article-title>
          <source>J Am Coll Cardiol</source>
          <date>
            <year>1999</year>
          </date>
          <fpage>759</fpage>
          <lpage>66</lpage>
          <issue>3</issue>
          <volume>33</volume>
          <person-group person-group-type="author">
            <name>
              <surname>Cohen-Solal</surname>
              <given-names>A</given-names>
            </name>
            <name>
              <surname>Esanu</surname>
              <given-names>Y</given-names>
            </name>
            <name>
              <surname>Logeart</surname>
              <given-names>D</given-names>
            </name>
            <name>
              <surname>Pessione</surname>
              <given-names>F</given-names>
            </name>
            <name>
              <surname>Dubois</surname>
              <given-names>C</given-names>
            </name>
            <name>
              <surname>Dreyfus</surname>
              <given-names>G</given-names>
            </name>
          </person-group>
        </element-citation>
      </ref>
      <ref id="B15">
        <mixed-citation>15. Diakakis GF, Parthenakis FI, Patrianakos     AP, Koukouraki SI, Stathaki MI, Karkavitsas NS, et al. Myocardial sympathetic     innervation in patients with impaired glucose tolerance: relationship to     subclinical inflammation. Cardiovasc Pathol. 2008;17(3):172-7.</mixed-citation>
        <element-citation publication-type="journal">
          <article-title>Myocardial sympathetic innervation in patients with impaired glucose tolerance: relationship to subclinical inflammation</article-title>
          <source>Cardiovasc Pathol</source>
          <date>
            <year>2008</year>
          </date>
          <fpage>172</fpage>
          <lpage>7</lpage>
          <issue>3</issue>
          <volume>17</volume>
          <person-group person-group-type="author">
            <name>
              <surname>Diakakis</surname>
              <given-names>GF</given-names>
            </name>
            <name>
              <surname>Parthenakis</surname>
              <given-names>FI</given-names>
            </name>
            <name>
              <surname>Patrianakos</surname>
              <given-names>AP</given-names>
            </name>
            <name>
              <surname>Koukouraki</surname>
              <given-names>SI</given-names>
            </name>
            <name>
              <surname>Stathaki</surname>
              <given-names>MI</given-names>
            </name>
            <name>
              <surname>Karkavitsas</surname>
              <given-names>NS</given-names>
            </name>
          </person-group>
        </element-citation>
      </ref>
      <ref id="B16">
        <mixed-citation>16. Dae MW, De Marco T, Botvinick EH, O'Connell     JW, Hattner RS, Huberty JP, et al. Scintigraphic assessment of MIBG uptake     in globally denervated human and canine hearts-implications for clinical     studies. J Nucl Med. 1992;33(8):1444-50.</mixed-citation>
        <element-citation publication-type="journal">
          <article-title>Scintigraphic assessment of MIBG uptake in globally denervated human and canine hearts-implications for clinical studies</article-title>
          <source>J Nucl Med</source>
          <date>
            <year>1992</year>
          </date>
          <fpage>1444</fpage>
          <lpage>50</lpage>
          <issue>8</issue>
          <volume>33</volume>
          <person-group person-group-type="author">
            <name>
              <surname>Dae</surname>
              <given-names>MW</given-names>
            </name>
            <name>
              <surname>De Marco</surname>
              <given-names>T</given-names>
            </name>
            <name>
              <surname>Botvinick</surname>
              <given-names>EH</given-names>
            </name>
            <name>
              <surname>O'Connell JW</surname>
            </name>
            <name>
              <surname>Hattner</surname>
              <given-names>RS</given-names>
            </name>
            <name>
              <surname>Huberty</surname>
              <given-names>JP</given-names>
            </name>
          </person-group>
        </element-citation>
      </ref>
      <ref id="B17">
        <mixed-citation>17. Ji SY, Travin MI. Radionuclide imaging     of cardiac autonomic innervation. J Nucl Cardiol. 2010;17(4):655-66.</mixed-citation>
        <element-citation publication-type="journal">
          <article-title>Radionuclide imaging of cardiac autonomic innervation</article-title>
          <source>J Nucl Cardiol</source>
          <date>
            <year>2010</year>
          </date>
          <fpage>655</fpage>
          <lpage>66</lpage>
          <issue>4</issue>
          <volume>17</volume>
          <person-group person-group-type="author">
            <name>
              <surname>Ji</surname>
              <given-names>SY</given-names>
            </name>
            <name>
              <surname>Travin</surname>
              <given-names>MI</given-names>
            </name>
          </person-group>
        </element-citation>
      </ref>
      <ref id="B18">
        <mixed-citation>18. Ando M, Yamamoto T, Hino A, Sato T, Nakamura     Y, Matsuzaki M. Norepinephrine spillover during exercise as a novel parameter     to evaluate the severity of heart failure. J Nucl Cardiol. 2010;17(5):868-73.</mixed-citation>
        <element-citation publication-type="journal">
          <article-title>Norepinephrine spillover during exercise as a novel parameter to evaluate the severity of heart failure</article-title>
          <source>J Nucl Cardiol</source>
          <date>
            <year>2010</year>
          </date>
          <fpage>868</fpage>
          <lpage>73</lpage>
          <issue>5</issue>
          <volume>17</volume>
          <person-group person-group-type="author">
            <name>
              <surname>Ando</surname>
              <given-names>M</given-names>
            </name>
            <name>
              <surname>Yamamoto</surname>
              <given-names>T</given-names>
            </name>
            <name>
              <surname>Hino</surname>
              <given-names>A</given-names>
            </name>
            <name>
              <surname>Sato</surname>
              <given-names>T</given-names>
            </name>
            <name>
              <surname>Nakamura</surname>
              <given-names>Y</given-names>
            </name>
            <name>
              <surname>Matsuzaki</surname>
              <given-names>M</given-names>
            </name>
          </person-group>
        </element-citation>
      </ref>
      <ref id="B19">
        <mixed-citation>19. Verberne HJ, Brewster LM, Somsen GA,     van Eck-Smit BL. Prognostic value of myocardial 123I-metaiodobenzylguanidine     (MIBG) parameters in patients with heart failure: a systematic review. Eur     Heart J. 2008;29(9):1147-59.</mixed-citation>
        <element-citation publication-type="journal">
          <article-title>Prognostic value of myocardial 123I-metaiodobenzylguanidine (MIBG) parameters in patients with heart failure: a systematic review</article-title>
          <source>Eur Heart J</source>
          <date>
            <year>2008</year>
          </date>
          <fpage>1147</fpage>
          <lpage>59</lpage>
          <issue>9</issue>
          <volume>29</volume>
          <person-group person-group-type="author">
            <name>
              <surname>Verberne</surname>
              <given-names>HJ</given-names>
            </name>
            <name>
              <surname>Brewster</surname>
              <given-names>LM</given-names>
            </name>
            <name>
              <surname>Somsen</surname>
              <given-names>GA</given-names>
            </name>
            <name>
              <surname>van Eck-Smit</surname>
              <given-names>BL</given-names>
            </name>
          </person-group>
        </element-citation>
      </ref>
      <ref id="B20">
        <mixed-citation>20.  Carri&#243; I, Cowie MR, Yamazaki     J, Udelson J, Camici PG. Cardiac sympathetic imaging with mIBG in heart failure.     JACC Cardiovasc Imaging. 2010;3(1):92-100.</mixed-citation>
        <element-citation publication-type="journal">
          <article-title>Cardiac sympathetic imaging with mIBG in heart failure</article-title>
          <source>JACC Cardiovasc Imaging</source>
          <date>
            <year>2010</year>
          </date>
          <fpage>92</fpage>
          <lpage>100</lpage>
          <issue>1</issue>
          <volume>3</volume>
          <person-group person-group-type="author">
            <name>
              <surname>Carri&#243;</surname>
              <given-names>I</given-names>
            </name>
            <name>
              <surname>Cowie</surname>
              <given-names>MR</given-names>
            </name>
            <name>
              <surname>Yamazaki</surname>
              <given-names>J</given-names>
            </name>
            <name>
              <surname>Udelson</surname>
              <given-names>J</given-names>
            </name>
            <name>
              <surname>Camici</surname>
              <given-names>PG</given-names>
            </name>
          </person-group>
        </element-citation>
      </ref>
      <ref id="B21">
        <mixed-citation>21. Ogita H, Shimonagata T, Fukunami M, Kumagai     K, Yamada T, Asano Y, et al. Prognostic significance of cardiac (123)I metaiodobenzylguanidine     imaging for mortality and morbidity in patients with chronic heart failure:     a prospective study. Heart. 2001;86(6):656-60.</mixed-citation>
        <element-citation publication-type="journal">
          <article-title>Prognostic significance of cardiac (123)I metaiodobenzylguanidine imaging for mortality and morbidity in patients with chronic heart failure: a prospective study</article-title>
          <source>Heart</source>
          <date>
            <year>2001</year>
          </date>
          <fpage>656</fpage>
          <lpage>60</lpage>
          <issue>6</issue>
          <volume>86</volume>
          <person-group person-group-type="author">
            <name>
              <surname>Ogita</surname>
              <given-names>H</given-names>
            </name>
            <name>
              <surname>Shimonagata</surname>
              <given-names>T</given-names>
            </name>
            <name>
              <surname>Fukunami</surname>
              <given-names>M</given-names>
            </name>
            <name>
              <surname>Kumagai</surname>
              <given-names>K</given-names>
            </name>
            <name>
              <surname>Yamada</surname>
              <given-names>T</given-names>
            </name>
            <name>
              <surname>Asano</surname>
              <given-names>Y</given-names>
            </name>
          </person-group>
        </element-citation>
      </ref>
      <ref id="B22">
        <mixed-citation>22. Fagard R, Pardaens K, Vanhaecke J. Prognostic     significance of exercise versus resting blood pressure in patients with chronic     heart failure. J Hypertens. 1999;17(12 Pt 2):1977-81.</mixed-citation>
        <element-citation publication-type="journal">
          <article-title>Prognostic significance of exercise versus resting blood pressure in patients with chronic heart failure</article-title>
          <source>J Hypertens</source>
          <date>
            <year>1999</year>
          </date>
          <fpage>1977</fpage>
          <lpage>81</lpage>
          <issue>12 Pt 2</issue>
          <volume>17</volume>
          <person-group person-group-type="author">
            <name>
              <surname>Fagard</surname>
              <given-names>R</given-names>
            </name>
            <name>
              <surname>Pardaens</surname>
              <given-names>K</given-names>
            </name>
            <name>
              <surname>Vanhaecke</surname>
              <given-names>J</given-names>
            </name>
          </person-group>
        </element-citation>
      </ref>
      <ref id="B23">
        <mixed-citation>23. Williams SG, Jackson M, Ng LL, Barker     D, Patwala A, Tan LB. Exercise duration and peak systolic blood pressure     are predictive of mortality in ambulatory patients with mild-moderate chronic     heart failure. Cardiology. 2005;104(4):221-6.</mixed-citation>
        <element-citation publication-type="journal">
          <article-title>Exercise duration and peak systolic blood pressure are predictive of mortality in ambulatory patients with mild-moderate chronic heart failure</article-title>
          <source>Cardiology</source>
          <date>
            <year>2005</year>
          </date>
          <fpage>221</fpage>
          <lpage>6</lpage>
          <issue>4</issue>
          <volume>104</volume>
          <person-group person-group-type="author">
            <name>
              <surname>Williams</surname>
              <given-names>SG</given-names>
            </name>
            <name>
              <surname>Jackson</surname>
              <given-names>M</given-names>
            </name>
            <name>
              <surname>Ng</surname>
              <given-names>LL</given-names>
            </name>
            <name>
              <surname>Barker</surname>
              <given-names>D</given-names>
            </name>
            <name>
              <surname>Patwala</surname>
              <given-names>A</given-names>
            </name>
            <name>
              <surname>Tan</surname>
              <given-names>LB</given-names>
            </name>
          </person-group>
        </element-citation>
      </ref>
      <ref id="B24">
        <mixed-citation>24. Costanzo MR, Augustine S, Bourge R, Bristow     M, O'Connell JB, Driscoll D, et al. Selection and treatment of candidates     for heart transplantation: a statement for health professionals from the     Committee on Heart Failure and Cardiac Transplantation of the Council on     Clinical Cardiology, American Heart Association. Circulation. 1995;92(12):3593-612.</mixed-citation>
        <element-citation publication-type="journal">
          <article-title>Selection and treatment of candidates for heart transplantation: a statement for health professionals from the Committee on Heart Failure and Cardiac Transplantation of the Council on Clinical Cardiology, American Heart Association</article-title>
          <source>Circulation</source>
          <date>
            <year>1995</year>
          </date>
          <fpage>3593</fpage>
          <lpage>612</lpage>
          <issue>12</issue>
          <volume>92</volume>
          <person-group person-group-type="author">
            <name>
              <surname>Costanzo</surname>
              <given-names>MR</given-names>
            </name>
            <name>
              <surname>Augustine</surname>
              <given-names>S</given-names>
            </name>
            <name>
              <surname>Bourge</surname>
              <given-names>R</given-names>
            </name>
            <name>
              <surname>Bristow</surname>
              <given-names>M</given-names>
            </name>
            <name>
              <surname>O'Connell JB</surname>
            </name>
            <name>
              <surname>Driscoll</surname>
              <given-names>D</given-names>
            </name>
          </person-group>
        </element-citation>
      </ref>
      <ref id="B25">
        <mixed-citation>25. Shakar SF, Lowes BD, Lindenfeld J, Zolty     R, Simon M, Robertson AD, et al. Peak oxygen consumption and outcome in heart     failure patients chronically treated with beta-blockers. J Card Fail. 2004;10(1):15-20.</mixed-citation>
        <element-citation publication-type="journal">
          <article-title>Peak oxygen consumption and outcome in heart failure patients chronically treated with beta-blockers</article-title>
          <source>J Card Fail</source>
          <date>
            <year>2004</year>
          </date>
          <fpage>15</fpage>
          <lpage>20</lpage>
          <issue>1</issue>
          <volume>10</volume>
          <person-group person-group-type="author">
            <name>
              <surname>Shakar</surname>
              <given-names>SF</given-names>
            </name>
            <name>
              <surname>Lowes</surname>
              <given-names>BD</given-names>
            </name>
            <name>
              <surname>Lindenfeld</surname>
              <given-names>J</given-names>
            </name>
            <name>
              <surname>Zolty</surname>
              <given-names>R</given-names>
            </name>
            <name>
              <surname>Simon</surname>
              <given-names>M</given-names>
            </name>
            <name>
              <surname>Robertson</surname>
              <given-names>AD</given-names>
            </name>
          </person-group>
        </element-citation>
      </ref>
      <ref id="B26">
        <mixed-citation>26. O'Neil JO, Young JB, Pothier CE, Lauer     MS. Peak oxygen consumption as a predictor of death in patients with heart     failure receiving beta-blockers. Circulation. 2005;111(18):2313-8.</mixed-citation>
        <element-citation publication-type="journal">
          <article-title>Peak oxygen consumption as a predictor of death in patients with heart failure receiving beta-blockers</article-title>
          <source>Circulation</source>
          <date>
            <year>2005</year>
          </date>
          <fpage>2313</fpage>
          <lpage>8</lpage>
          <issue>18</issue>
          <volume>111</volume>
          <person-group person-group-type="author">
            <name>
              <surname>O'Neil JO</surname>
            </name>
            <name>
              <surname>Young</surname>
              <given-names>JB</given-names>
            </name>
            <name>
              <surname>Pothier</surname>
              <given-names>CE</given-names>
            </name>
            <name>
              <surname>Lauer</surname>
              <given-names>MS</given-names>
            </name>
          </person-group>
        </element-citation>
      </ref>
      <ref id="B27">
        <mixed-citation>27. Willens HJ, Blevins RD, Wrisley D, Antonishen     D, Reinstein D, Rubenfire M. The prognostic value of functional capacity     in patients with mild to moderate heart failure. Am Heart J. 1987;114(2):377-82.</mixed-citation>
        <element-citation publication-type="journal">
          <article-title>The prognostic value of functional capacity in patients with mild to moderate heart failure</article-title>
          <source>Am Heart J</source>
          <date>
            <year>1987</year>
          </date>
          <fpage>377</fpage>
          <lpage>82</lpage>
          <issue>2</issue>
          <volume>114</volume>
          <person-group person-group-type="author">
            <name>
              <surname>Willens</surname>
              <given-names>HJ</given-names>
            </name>
            <name>
              <surname>Blevins</surname>
              <given-names>RD</given-names>
            </name>
            <name>
              <surname>Wrisley</surname>
              <given-names>D</given-names>
            </name>
            <name>
              <surname>Antonishen</surname>
              <given-names>D</given-names>
            </name>
            <name>
              <surname>Reinstein</surname>
              <given-names>D</given-names>
            </name>
            <name>
              <surname>Rubenfire</surname>
              <given-names>M</given-names>
            </name>
          </person-group>
        </element-citation>
      </ref>
      <ref id="B28">
        <mixed-citation>28. Jeng C, Yang MH, Chen PL, Ho CH. The     influence of exercise tolerance on quality of life among patients with heart     failure. Qual Life Res. 2004;13(5):925-32.</mixed-citation>
        <element-citation publication-type="journal">
          <article-title>The influence of exercise tolerance on quality of life among patients with heart failure</article-title>
          <source>Qual Life Res</source>
          <date>
            <year>2004</year>
          </date>
          <fpage>925</fpage>
          <lpage>32</lpage>
          <issue>5</issue>
          <volume>13</volume>
          <person-group person-group-type="author">
            <name>
              <surname>Jeng</surname>
              <given-names>C</given-names>
            </name>
            <name>
              <surname>Yang</surname>
              <given-names>MH</given-names>
            </name>
            <name>
              <surname>Chen</surname>
              <given-names>PL</given-names>
            </name>
            <name>
              <surname>Ho</surname>
              <given-names>CH</given-names>
            </name>
          </person-group>
        </element-citation>
      </ref>
      <ref id="B29">
        <mixed-citation>29. Rubim VS, Drumond Neto C, Romeo JL, Montera     MW. Valor progn&#243;stico do teste de caminhada de seis minutos na insufici&#234;ncia     card&#237;aca. Arq Bras Cardiol. 2006;86(2):120-5.</mixed-citation>
        <element-citation publication-type="journal">
          <article-title>Valor progn&#243;stico do teste de caminhada de seis minutos na insufici&#234;ncia card&#237;aca</article-title>
          <source>Arq Bras Cardiol</source>
          <date>
            <year>2006</year>
          </date>
          <fpage>120</fpage>
          <lpage>5</lpage>
          <issue>2</issue>
          <volume>86</volume>
          <person-group person-group-type="author">
            <name>
              <surname>Rubim</surname>
              <given-names>VS</given-names>
            </name>
            <name>
              <surname>Drumond Neto</surname>
              <given-names>C</given-names>
            </name>
            <name>
              <surname>Romeo</surname>
              <given-names>JL</given-names>
            </name>
            <name>
              <surname>Montera</surname>
              <given-names>MW</given-names>
            </name>
          </person-group>
        </element-citation>
      </ref>
      <ref id="B30">
        <mixed-citation>30. Myers J, Zaheer N, Quaglietti S, Madhavan     R, Froelicher V, Heidenreich P. Association of functional and health status     measures in heart failure. J Card Fail. 2006;12(6):439-45.</mixed-citation>
        <element-citation publication-type="journal">
          <article-title>Association of functional and health status measures in heart failure</article-title>
          <source>J Card Fail</source>
          <date>
            <year>2006</year>
          </date>
          <fpage>439</fpage>
          <lpage>45</lpage>
          <issue>6</issue>
          <volume>12</volume>
          <person-group person-group-type="author">
            <name>
              <surname>Myers</surname>
              <given-names>J</given-names>
            </name>
            <name>
              <surname>Zaheer</surname>
              <given-names>N</given-names>
            </name>
            <name>
              <surname>Quaglietti</surname>
              <given-names>S</given-names>
            </name>
            <name>
              <surname>Madhavan</surname>
              <given-names>R</given-names>
            </name>
            <name>
              <surname>Froelicher</surname>
              <given-names>V</given-names>
            </name>
            <name>
              <surname>Heidenreich</surname>
              <given-names>P</given-names>
            </name>
          </person-group>
        </element-citation>
      </ref>
      <ref id="B31">
        <mixed-citation>31. Chandrashekhar Y, Anand IS. Can common     exercise indices determine peak exercise oxygen consumption and anaerobic     threshold during stress testing in patients with chronic congestive heart     failure? Indian Heart J. 1993;45(6):493-5.</mixed-citation>
        <element-citation publication-type="journal">
          <article-title>Can common exercise indices determine peak exercise oxygen consumption and anaerobic threshold during stress testing in patients with chronic congestive heart failure</article-title>
          <source>Indian Heart J</source>
          <date>
            <year>1993</year>
          </date>
          <fpage>493</fpage>
          <lpage>5</lpage>
          <issue>6</issue>
          <volume>45</volume>
          <person-group person-group-type="author">
            <name>
              <surname>Chandrashekhar</surname>
              <given-names>Y</given-names>
            </name>
            <name>
              <surname>Anand</surname>
              <given-names>IS</given-names>
            </name>
          </person-group>
        </element-citation>
      </ref>
      <ref id="B32">
        <mixed-citation>32.  Parikh KH, Hetal A, Milan C, Urmil G,     Hemang A, Anish C, Ajay M, et al. Effect of Metoprolol CR/XL on pulmonary     artery pressure in chronic heart failure patients assessed by an implanted     ultrasonic device with special emphasis on diurnal variation and exercise     capacity. Indian Heart J. 2009;61(1):34-9.</mixed-citation>
        <element-citation publication-type="journal">
          <article-title>Effect of Metoprolol CR/XL on pulmonary artery pressure in chronic heart failure patients assessed by an implanted ultrasonic device with special emphasis on diurnal variation and exercise capacity</article-title>
          <source>Indian Heart J</source>
          <date>
            <year>2009</year>
          </date>
          <fpage>34</fpage>
          <lpage>9</lpage>
          <issue>1</issue>
          <volume>61</volume>
          <person-group person-group-type="author">
            <name>
              <surname>Parikh</surname>
              <given-names>KH</given-names>
            </name>
            <name>
              <surname>Hetal</surname>
              <given-names>A</given-names>
            </name>
            <name>
              <surname>Milan</surname>
              <given-names>C</given-names>
            </name>
            <name>
              <surname>Urmil</surname>
              <given-names>G</given-names>
            </name>
            <name>
              <surname>Hemang</surname>
              <given-names>A</given-names>
            </name>
            <name>
              <surname>Anish</surname>
              <given-names>C</given-names>
            </name>
            <name>
              <surname>Ajay</surname>
              <given-names>M</given-names>
            </name>
          </person-group>
        </element-citation>
      </ref>
      <ref id="B33">
        <mixed-citation>33. Poelzl G, Frick M, Lackner B, Huegel     H, Alber HF, Mair J, et al. Short-term improvement in submaximal exercise     capacity by optimized therapy with ACE inhibitors and beta blockers in heart     failure patients is associated with restoration of peripheral endothelial     function. Int J Cardiol. 2006;108(1):48-54.</mixed-citation>
        <element-citation publication-type="journal">
          <article-title>Short-term improvement in submaximal exercise capacity by optimized therapy with ACE inhibitors and beta blockers in heart failure patients is associated with restoration of peripheral endothelial function</article-title>
          <source>Int J Cardiol</source>
          <date>
            <year>2006</year>
          </date>
          <fpage>48</fpage>
          <lpage>54</lpage>
          <issue>1</issue>
          <volume>108</volume>
          <person-group person-group-type="author">
            <name>
              <surname>Poelzl</surname>
              <given-names>G</given-names>
            </name>
            <name>
              <surname>Frick</surname>
              <given-names>M</given-names>
            </name>
            <name>
              <surname>Lackner</surname>
              <given-names>B</given-names>
            </name>
            <name>
              <surname>Huegel</surname>
              <given-names>H</given-names>
            </name>
            <name>
              <surname>Alber</surname>
              <given-names>HF</given-names>
            </name>
            <name>
              <surname>Mair</surname>
              <given-names>J</given-names>
            </name>
          </person-group>
        </element-citation>
      </ref>
      <ref id="B34">
        <mixed-citation>34. Jacobson AF, Senior R, Cerqueira MD,     Wong ND, Thomas GS, Lopez VA, et al. Myocardial iodine-123 meta-iodobenzylguanidine     imaging and cardiac events in heart failure: results of the prospective ADMIRE-HF     (AdreView Myocardial Imaging for Risk Evaluation in Heart Failure) study.     J Am Coll Cardiol. 2010;55(20):2212-21.</mixed-citation>
        <element-citation publication-type="journal">
          <article-title>Myocardial iodine-123 meta-iodobenzylguanidine imaging and cardiac events in heart failure: results of the prospective ADMIRE-HF (AdreView Myocardial Imaging for Risk Evaluation in Heart Failure) study</article-title>
          <source>J Am Coll Cardiol</source>
          <date>
            <year>2010</year>
          </date>
          <fpage>2212</fpage>
          <lpage>21</lpage>
          <issue>20</issue>
          <volume>55</volume>
          <person-group person-group-type="author">
            <name>
              <surname>Jacobson</surname>
              <given-names>AF</given-names>
            </name>
            <name>
              <surname>Senior</surname>
              <given-names>R</given-names>
            </name>
            <name>
              <surname>Cerqueira</surname>
              <given-names>MD</given-names>
            </name>
            <name>
              <surname>Wong</surname>
              <given-names>ND</given-names>
            </name>
            <name>
              <surname>Thomas</surname>
              <given-names>GS</given-names>
            </name>
            <name>
              <surname>Lopez</surname>
              <given-names>VA</given-names>
            </name>
          </person-group>
        </element-citation>
      </ref>
      <ref id="B35">
        <mixed-citation>35. Kasama S, Toyama T, Hatori T, Sumino     H, Kumakura H, Takayama Y, et al. Evaluation of cardiac sympathetic nerve     activity and left ventricular remodelling in patients with dilated cardiomyopathy     on the treatment containing carvedilol. Eur Heart J. 2007;28(8):989-95.</mixed-citation>
        <element-citation publication-type="journal">
          <article-title>Evaluation of cardiac sympathetic nerve activity and left ventricular remodelling in patients with dilated cardiomyopathy on the treatment containing carvedilol</article-title>
          <source>Eur Heart J</source>
          <date>
            <year>2007</year>
          </date>
          <fpage>989</fpage>
          <lpage>95</lpage>
          <issue>8</issue>
          <volume>28</volume>
          <person-group person-group-type="author">
            <name>
              <surname>Kasama</surname>
              <given-names>S</given-names>
            </name>
            <name>
              <surname>Toyama</surname>
              <given-names>T</given-names>
            </name>
            <name>
              <surname>Hatori</surname>
              <given-names>T</given-names>
            </name>
            <name>
              <surname>Sumino</surname>
              <given-names>H</given-names>
            </name>
            <name>
              <surname>Kumakura</surname>
              <given-names>H</given-names>
            </name>
            <name>
              <surname>Takayama</surname>
              <given-names>Y</given-names>
            </name>
          </person-group>
        </element-citation>
      </ref>
    </ref-list>
  </back>
  <sub-article article-type="translation" id="TRen" xml:lang="en">
    <front-stub>
      <article-categories>
        <subj-group subj-group-type="heading">
          <subject>Original Articles</subject>
        </subj-group>
      </article-categories>
      <title-group>
        <article-title xml:lang="en">Relationship between cardiac adrenergic image and exercise testing in heart failure</article-title>
      </title-group>
      <abstract xml:lang="en">
        <p>BACKGROUND: The exercise treadmill test can be used in ventricular dysfunction patients for functional capacity or predicting prognosis. The cardiac image with 123I MIBG shows cardiac sympathetic activation. OBJECTIVE: To evaluate the relationship between exercise treadmill test variables and cardiac image changes in 123I MIBG. METHODS: 23 patients with LVEF &lt; 45% performed scintigraphy cardiac with 123I MIBG and divided into two groups. G1: Washout rate &lt; 27%; G2: &gt; 27%. Systolic blood pressure (SBP), heart rate (HR) and functional capacity were evaluated. It was performed Student t test or Mann-Whitney U test, Spearman coefficient and linear regression. RESULTS: SBP at exercise peak (G1: 181.00 &#177; 28.01; G2: 153.27 &#177; 27.71 mmHg, p = 0.027), SBP variation [G1: 64(47.5-80.5); G2: 36(25-47) mmHg, p = 0.015], the HR at exercise peak (G1: 136.91 &#177; 19.66; G2: 118.45 &#177; 13.98 bpm, p = 0.018) and chronotropic response (G1: 70.42 &#177; 17.94; G2: 49.47 &#177; 14.89%, p = 0.006), and functional capacity [G1: 8.37(6.47-10.27); G2: 4.42(2.46-6.38) METs, p = 0.003] were smaller in G2 group. There was negative correlation between Washout rate and SBP at exercise peak (r = -0.505, p = 0.014), variation in SBP (r = -0.493, p = 0.017) and functional capacity (r = -0.646, p = 0.001). Nevertheless, SBP at exercise peak (r = -0.422, p = 0.016) and functional capacity (r = -0.804, p = 0.004) were the only variables associated with Washout rate, after linear regression. CONCLUSION: In heart failure patients, the SBP at exercise peak and functional capacity were the variables associated with Washout rate.</p>
      </abstract>
      <kwd-group xml:lang="en">
        <kwd>MIBG</kwd>
        <kwd>exercise test</kwd>
        <kwd>heart failure</kwd>
      </kwd-group>
    </front-stub>
    <body>
      <p>
        <bold>ORIGINAL ARTICLE</bold>
      </p>
      <fig id="title-body2"/>
      <p>Relationship between cardiac adrenergic image and exercise testing in heart failure</p>
      <p>
        <bold>Leandro Rocha Messias<sup>I</sup>; Maria &#194;ngela M. de Queiroz Carreira<sup>I</sup>; Sandra Marina Ribeiro de Miranda<sup>I</sup>; Jader Cunha de Azevedo<sup>I,II</sup>; Isabela Ambr&#243;sio Gava<sup>I</sup>; Ronaldo Campos Rodrigues<sup>I</sup>; Elizabeth Mar&#243;stica<sup>I</sup>; Ant&#244;nio Claudio Lucas da N&#243;brega<sup>I,II</sup>; Claudio Tinoco Mesquita<sup>I,II</sup></bold>
      </p>
      <p><sup>I</sup>Universidade Federal Fluminense, Niter&#243;i, RJ</p>
      <p><sup>II</sup>Hospital Procard&#237;aco, Rio de Janeiro, RJ - Brazil</p>
      <p>Mailing address</p>
      <p>
        <bold>ABSTRACT</bold>
      </p>
      <p><bold>BACKGROUNDS: </bold>The exercise treadmill test can be used in ventricular dysfunction patients for functional capacity or predicting prognosis. The cardiac image with 123I MIBG shows cardiac sympathetic activation.</p>
      <p><bold>OBJECTIVE: </bold>To evaluate the relationship between exercise treadmill test variables and cardiac image changes in 123I MIBG.</p>
      <p><bold>METHODS: </bold>23 patients with LVEF <underline>&lt;</underline> 45% performed scintigraphy cardiac with 123I MIBG and divided into two groups. G1: Washout rate &lt; 27%; G2: <underline>&gt;</underline> 27%. Systolic blood pressure (SBP), heart rate (HR) and functional capacity were evaluated. It was performed Student t test or Mann-Whitney U test, Spearman coefficient and linear regression.</p>
      <p><bold>RESULTS: </bold>SBP at exercise peak (G1: 181.00 &#177; 28.01; G2: 153.27 &#177; 27.71 mmHg, p = 0.027), SBP variation [G1: 64(47.5-80.5); G2: 36(25-47) mmHg, p = 0.015], the HR at exercise peak (G1: 136.91 &#177; 19.66; G2: 118.45 &#177; 13.98 bpm, p = 0.018) and chronotropic response (G1: 70.42 &#177; 17.94; G2: 49.47 &#177; 14.89%, p = 0.006), and functional capacity [G1: 8.37(6.47-10.27); G2: 4.42(2.46-6.38) METs, p = 0.003] were smaller in G2 group. There was negative correlation between Washout rate and SBP at exercise peak (r = -0.505, p = 0.014), variation in SBP (r = -0.493, p = 0.017) and functional capacity (r = -0.646, p = 0.001). Nevertheless, SBP at exercise peak (r = -0.422, p = 0.016) and functional capacity (r = -0.804, p = 0.004) were the only variables associated with Washout rate, after linear regression.</p>
      <p><bold>CONCLUSION: </bold>In heart failure patients, the SBP at exercise peak and functional capacity were the variables associated with Washout rate.</p>
      <p><bold>Key words: </bold>MIBG, exercise test; heart failure.</p>
      <p>
        <bold>Introduction</bold>
      </p>
      <p>In heart failure (HF), exercise testing (ET) is used to evaluate functional capacity, symptoms and therapy<sup>1</sup>. Some of the parameters used in ET are the behavior of systolic blood pressure (SBP) intrastress and chronotropic reserve, which are recognized predictors of prognosis<sup>2-4</sup>. The adrenergic hyperactivity, a characteristic of HF, may lead to chronotropic incompetence, decrease in cardiac contractile response to catecholamines and decreased sympathetic reserve during exercise. An inadequate response in SBP and heart rate (HR) has been associated with a twofold risk of mortality and adverse cardiovascular events<sup>2,5-7</sup>. Both for the population<sup>8</sup>, and in the population with HF<sup>2,9</sup>, functional capacity is an important predictor of prognosis and is not related to measures of ventricular function at rest nor with left ventricular ejection fraction<sup>10</sup>.</p>
      <p>The activity and cardiac sympathetic innervation can be evaluated by scintigraphy with metaiodobenzylguanidine labeled with iodine 123 (I<sup>123</sup> MIBG)<sup>11-13</sup>. Studies have found<sup>13-16</sup> that an early image represents the integrity of presynaptic nerve terminals and the density of betarreceptors. The presynaptic neuronal imaging contributes to the late image, combining information of neural function including capture, storage and release of norepinephrine in the presynaptic vesicles. The washout rate is a parameter that evaluates the degree of sympathetic activity. HF patients may have: (1) reduced tracer imaging due to loss of sympathetic neurons and/or disorders in primary uptake of norepinephrine; and (2) increased washout rate, reflecting the spillover of noradrenaline to the blood stream<sup>11,14,17-19</sup>. A washout rate smaller than 27% is a strong predictor descriptor of survival<sup>20</sup>.</p>
      <p>So far, there is no evidence that the adrenergic hyperactivation at rest is associated with hemodynamic changes during exercise, or if the ET variables are associated with the scintigraphy variables. Therefore, the purpose of this study is to assess whether conventional ET variables in HF can detect patients with sympathetic dysfunction in I<sup>123</sup> MIBG scintigraphy. These findings could allow the assessment of risk with a technique available in our area, selecting those patients most likely to present changes to scintigraphy.</p>
      <p>
        <bold>Methods</bold>
      </p>
      <p>We selected 23 consecutive patients treated at the HF outpatient clinic of Hospital Universit&#225;rio Ant&#244;nio Pedro, Universidade Federal Fluminense. The selected patients had heart failure and left ventricular ejection fraction smaller than or equal to 45% measured by echocardiography by Simpson's technique. The study excluded patients who had: atrial fibrillation, diabetic patients, patients with ventricular pacing device, endocrine disorders, Parkinson's disease, pregnant or breastfeeding women. No medication has been suspended for the study and all patients were treated with optimized doses of standard drugs for HF, including beta-blocker (carvedilol). Volunteers signed a consent form agreeing to be part of the project. The project was approved by the Research Ethics Committee of Hospital Universit&#225;rio Ant&#244;nio Pedro, under number 011/09. </p>
      <p>Patients underwent symptom-limited ET (ErgoPC 13 software version 2.2) on a treadmill, brand Imbramed, properly calibrated to manufacturer's directions, in the ramp protocol. We evaluated the behavior of systolic blood pressure (SBP), intrastress heart rate (HR) and functional capacity. The blood pressure measurement was performed by the indirect method using mercury column sphygmomanometer, duly calibrated, measured in the left arm of patients in the standing position. Heart rate was measured through RR interval of eletrocardiogram (ECG) by the software. SBP and HR at peak exercise, SBP variation at peak exercise compared to rest (&#916; PAS) and index of chronotropic reserve were evaluated using the formula: <italic>("{[HR at peak exercise - resting HR / (220 - age) - resting HR] x 100}")</italic><sup>4</sup>. Functional capacity was estimated by the software according to the workload achieved. </p>
      <p>Patients underwent myocardial scintigraphy with I&#185;&#178;&#179; MIBG to assess cardiac adrenergic innervation, through radiotracer, by studying the heart/mediastinum relationship (H/M) for early images (30 minutes) and late images (4 hours), besides calculation of the washout rate {<italic>[(H/M early - H/M late) / (H/M early)] x 100}</italic><sup>11</sup>. All scintigraphic examinations were performed at Servi&#231;o de Medicina Nuclear do Hospital Pr&#243;-Card&#237;aco do Rio de Janeiro in Anger type digital CT scintillation camera (Single Photon Emission Computed Tomography) brand Siemens, E-Cam dual detector model, with low energy collimator and high resolution. </p>
      <p>Patients were divided into two groups according to the washout (WO) rate: Group 1 (G1), washout rate &lt; 27% (normal); Group 2 (G2), washout rate <underline>&gt;</underline> 27% (amended)<sup>21</sup>. For the statistical analysis, software SPSS version 15 was used. For the evaluation of qualitative variables, we used the chi-square test. To evaluate the quantitative variables we used the Student t test or Mann-Whitney U test, according to data distribution. We used the Spearman correlation coefficient to evaluate the correlation of the variables of exercise with the WO. We used stepwise linear regression to identify variables associated with sympathetic hypertonia evaluated by the washout rate. Statistical significance was considered when p &lt; 0.05.</p>
      <p>
        <bold>Results</bold>
      </p>
      <p>Patient characteristics are shown in <xref ref-type="table" rid="tab01-body2">Table 1</xref>. There were no significant differences in age, sex, body mass index, etiology of HF, left ventricular ejection fraction, medications and dosage of carvedilol between groups.</p>
      <table-wrap id="tab01-body2">
        <graphic xlink:href="1678-4170-abc-96-05-0370-00044-gt01-en.jpg"/></table-wrap>
      <p>The groups were similar at rest. At peak exercise, there was a significant difference between G1 and G2, but the latter had lower absolute values of SBP and HR, smaller intrastress SBP variation, lower rate of chronotropic reserve and a lower functional capacity. The parameters of the exercise are shown in <xref ref-type="table" rid="tab02-body2">Table 2</xref> and <xref ref-type="fig" rid="fig01-body2">Figure 1</xref> shows the differences in SBP during exercise.</p>
      <table-wrap id="tab02-body2">
        <graphic xlink:href="1678-4170-abc-96-05-0370-00044-gt02-en.jpg"/></table-wrap>
      <fig id="fig01-body2">
        <graphic xlink:href="1678-4170-abc-96-05-0370-00044-gf01-en.jpg"/></fig>
      <p>Though divided by the washout rate, there was no significant difference in the early C/M ratio of I<sup>123</sup> MIBG (G1: 1.78 &#177; 0.25 <italic>vs</italic> G2: 1.74 &#177; 0.22, p = 0.710) and in late H/M ratio (G1: 1,74 &#177; 0,20 <italic>vs</italic> G2: 1,60 &#177; 0,22; p = 0.129). <xref ref-type="fig" rid="fig02-body2">Figure 2</xref> illustrates the cardiac imaging with I<sup>123</sup> MIBG in a patient with HF presenting normal HF parameters (functional capacity of 8.23 METs, intrastress SBP variation of 65 mmHg and chronotropic reserve index of 68%). The MIBG imaging was normal and the washout rate was 21%.</p>
      <fig id="fig02-body2">
        <graphic xlink:href="1678-4170-abc-96-05-0370-00044-gf02-en.jpg"/></fig>
      <p>When we analyzed the correlation between exercise variables and the washout rate, we observed a significant negative correlation between the washout rate and the following variables: SBP at peak exercise, intrastress SBP variation and functional capacity (<xref ref-type="table" rid="tab03-body2">Table 3</xref>). No statistical significance was found in correlation with HR at peak exercise and chronotropic reserve index with WO (<xref ref-type="table" rid="tab03-body2">Table 3</xref>).</p>
      <table-wrap id="tab03-body2">
        <graphic xlink:href="1678-4170-abc-96-05-0370-00044-gt03-en.jpg"/></table-wrap>
      <p>After stepwise linear regression, the variables associated with dysautonomia by the washout rate were: SBP at peak exercise (r = -0.422; p = 0.016) and functional capacity in METs (r = -0.804; p = 0.004). </p>
      <p>
        <bold>Discussion</bold>
      </p>
      <p>In our study, we found that in patients with HF, SBP at peak exercise and functional capacity, measured by the number of METs achieved, are associated with changes in cardiac adrenergic innervation, as evidenced by the washout rate obtained by myocardial scintigraphy with I<sup>123</sup> MIBG. During ET, in patients with altered washout rate (state of adrenergic hypertonia at rest), we found that SBP at peak exercise and the number of METs showed lower values when compared with patients with normal washout rate. So far, there are no descriptions in literature of the association between such abnormal behavior in SBP and changes in cardiac adrenergic innervation by I<sup>123</sup> MIBG.</p>
      <p>The variation in SBP during exercise is directly associatedwith cardiac output during exercise: a lower increase in intrastress SBP may result from inotropic deficit during the exercise, which is a common phenomenon in patients with ventricular dysfunction, and this finding is associated with a worse prognosis<sup>2</sup>. Fargard et al<sup>22</sup> in a sample of patients eligible for heart transplantation, demonstrated that an inadequate variation in SBP in response to submaximal exercise is a predictor of cardiac events. </p>
      <p>Willians et al<sup>23</sup> evaluated patients with HF of different functional classes, demonstrating that simple parameters from the test, such as the duration and peak exercise SBP, are strong predictors of prognosis through multivariate analysis, exceeding the left ventricular ejection fraction and N-terminal proBNP ejection fraction (NT-proBNP). </p>
      <p>Nishiyama et al<sup>2</sup> evaluated the blood pressure response during exercise as a predictor of prognosis in patients with HF. Through univariate analysis, SBP and HR at peak exercise, and their variations during exercise (&#916;SBP/&#916;HR = peak exercise - rest) were predictors of mortality. In this study, the group not surviving presented significantly lower values of these variables. After multivariate analysis, the &#916; SBP and functional capacity, obtained through the number of METs achieved, were the best predictors of mortality, regardless of the use of beta-blockers. </p>
      <p>Maximal oxygen consumption (VO<sub>2</sub>) is a parameter used to assess, in patients with heart failure, eligible to cardiac transplantation<sup>24</sup>, and is also a powerful predictor of prognosis<sup>24-26</sup>. Willens et al<sup>27</sup> studying 40 patients with HF, functional class II and III of the New York Heart Association (NYHA), have shown that VO<sub>2</sub> max, both by indirect measurement (according to the time of the year), and by direct measurement, through the Cardiopulmonary Exercise Testing, is an important predictor of survival, providing useful information for monitoring patients. Another way to assess VO<sub>2 </sub>max by indirect measurement is by the number of METs achieved on the NT<sup>2</sup>.</p>
      <p>In a study involving healthy individuals Snader et al<sup>8</sup> demonstrated that functional capacity was a powerful predictor of cardiovascular mortality. In this study, the rate of cardiovascular mortality was higher in the group that failed to reach 06 METs on ET, and its association with perfusion defects diagnosed by thallium scintigraphy, put these patients at a risk level even higher for adverse events.</p>
      <p>Jeng et al<sup>28</sup> evaluated the influence of exercise tolerance on the quality of life in patients with HF. Patients who had a functional capacity greater than or equal to 05 METs, or a time of ET greater than or equal to 180 seconds, had a better quality of life, showing that the ET is safe, affordable and effective to assess exercise tolerance in this population. Rubim et al<sup>29</sup> showed that the number of METs achieved in ET correlated significantly with mortality. </p>
      <p>Myers et al<sup>30</sup>, evaluating quality of life scores, 06-minute walking test and number of METs achieved on ET in patients with HF, and correlating these variables with VO<sub>2</sub> max obtained through cardiopulmonary exercise testing, concluded that both reflect the patient's clinical status and have their importance in this clinical context, without, however, substituting one another. When compared to the distance covered in the 06-minute walking test, the functional capacity determined by the number of METs in ET correlated significantly better with the VO<sub>2</sub> max obtained through direct measurement. </p>
      <p>Chandrashekhar et al<sup>31</sup> analyzed the capacity of variables commonly used in ET in predicting VO<sub>2</sub> max. After stepwise regression analysis, the best predictor of VO<sub>2</sub> max was the number of METs achieved. Although the authors assert that the number of METs do not have a high precision, it still is a better predictor than the other clinical variables obtained, such as the HR behavior during exercise. </p>
      <p>One of the most significant changes in the treatment of heart failure was the introduction of beta blockers. Parikh et al<sup>32</sup>, in HF patients, NYHA functional class III and IV, evaluated the effect of the beta-blocker metoprolol on the number of METs achieved on ET and concluded that the optimization of beta-blocker improves exercise performance, measured both by exercising time, and by the number METs.</p>
      <p>Some studies suggest that the improvement, which is not universally observed, may be partly due to improved endothelial function due to the use of beta-blockers associated with inhibitor of angiotensin-converting enzyme<sup>33</sup>. </p>
      <p>Another aspect of risk markers in HF is through the neuroimaging. I<sup>123</sup> MIBG scintigraphy has been validated as a marker of prognosis, according to a meta-analysis with 1,755 patients, published by Verbene et al<sup>19</sup> who demonstrated that a reduction of the C/M ratio in late imaging or washout rate increase in myocardial scintigraphy I<sup>123</sup> MIBG is associated with a worse prognosis when compared with patients with normal parameters. In a recent publication, Jacobson et al<sup>34</sup> in a multicenter study with patients with functional class NYHA II and III and left ventricular ejection fraction smaller than 35%, showed that the adrenergic direct assessment of the heart by myocardial scintigraphy with I<sup>123</sup> MIBG, was predictive of increased cardiac mortality and arrhythmic events, regardless of known prognostic factors such as left ventricular ejection fraction, brain natriuretic peptide levels and NYHA functional class. </p>
      <p>Analyzing the functional information obtained by the neuroimaging with Cardiopulmonary Exercise Test, Cohen-Solal et al<sup>14</sup> correlated VO<sub>2</sub> max with I<sup>123</sup> MIBG uptake and several other variables (left ventricular ejection fraction, hemodynamic parameters such as cardiac index and pulmonary capillary wedge pressure). Observed a significant correlation between adrenergic scintigraphic findings in I<sup>123</sup> MIBG and VO<sub>2</sub> max in the exercise. Analyzing their outcomes (cardiovascular death and heart transplantation), the major determinant of prognosis was VO<sub>2</sub> max. VO<sub>2</sub> max correlated better with the C/M ratio for late image than with the C/M to ratio for early image and the washout rate. In contrast, our study found a higher correlation with the washout rate with the number of METs achieved, rather than with late C/M ratio as in the study by Cohen-Solal et al<sup>14</sup>.</p>
      <p>However, there are significant differences between the studies: In our study, we assessed VO<sub>2</sub> max by indirect measurement through the number of METs achieved, while Cohen-Solal et al<sup>14</sup> have used a direct measurement of the VO<sub>2</sub>. In the study by Cohen-Solal et al, only 13.0% of patients were taking beta-blockers, while in our study, all patients were using this medication. One of the actions of beta blockers is resensibilizing betareceptors, which may influence the C/M ratio, which could explain the differences between findings<sup>5,35</sup>.</p>
      <p>
        <bold>Study limitations</bold>
      </p>
      <p>The main limitation in this study was the small number of patients. However, through a pilot study with 16 patients, a sample calculation was performed and the number of 23 patients has a statistical power of 90% to identify 50% difference in functional capacity and a statistical power of 80% to identify 50% of difference in SBP at peak exercise.</p>
      <p>Another significant limitation is that we have employed the functional capacity by the number of METs achieved, rather than the VO<sub>2</sub> max calculated directly through cardiopulmonary exercise testing, because we did not have the necessary equipment at our institution at the time of this study. However, as the ET is a simple tool widely present in our environment, we believe that the information derived from this examination may be useful for cardiologists involved in clinical practice of patients with HF, since it is correlated with the sophisticated analysis of cardiac innervation. Another important variable observed as significant in our study was that SBP at peak exercise, is also derived from ET and does not require complex methodologies for analysis.</p>
      <p>
        <bold>Conclusion</bold>
      </p>
      <p>Patients with HF and washout rate changed in I<sup>123</sup> MIBG myocardial scintigraphy showed a lower inotropic and chronotropic response, and a lower functional capacity. SBP at peak exercise and the number of METs were the ET variables most associated with this adrenergic hypertonia assessed by scintigraphy. Conventional ET, through the evaluation of these two variables, can be used as a way to predict the presence of adrenergic hyperactivity in patients with heart failure.</p>
      <p>
        <bold>Acknowledge</bold>
      </p>
      <p>Acknowledge to FAPERJ and CNPq for the support given to research projects conducted by <italic>Universidade Federal Fluminense</italic>.</p>
      <p>
        <bold>Potential Conflict of Interest</bold>
      </p>
      <p>No potential conflict of interest relevant to this article was reported.</p>
      <p>
        <bold>Sources of Funding</bold>
      </p>
      <p>There were no external funding sources for this study.</p>
      <p>
        <bold>Study Association</bold>
      </p>
      <p>This article is part of the thesis of master submitted by Leandro Rocha Messias, from <italic>Universidade Federal Fluminense</italic>.</p>
      <p>
        <bold>References</bold>
      </p>
    </body>
  </sub-article>
  <sub-article article-type="translation" id="TRes" xml:lang="es">
    <front-stub>
      <article-categories/>
      <title-group>
        <article-title xml:lang="es">Relaci&#243;n entre imagen adren&#233;rgica card&#237;aca y ergometr&#237;a en la insuficiencia card&#237;aca</article-title>
      </title-group>
      <abstract xml:lang="es">
        <p>FUNDAMENTOS: En la Insuficiencia Card&#237;aca, la Ergometr&#237;a (Test Ergom&#233;trico - TE) eval&#250;a la capacidad funcional, un determinante de pron&#243;stico. El centellograma con I&#185;&#178;&#179; MIBG muestra la activaci&#243;n simp&#225;tica card&#237;aca. OBJETIVO: Evaluar la asociaci&#243;n entre las variables del TE y las alteraciones del centellograma con I&#185;&#178;&#179; MIBG. M&#201;TODOS: Se sometieron 23 pacientes (FEVI &lt; 45%) a centellograma con I&#185;&#178;&#179; MIBG y se separaron en: G1) tasa de Washout &lt; 27%; G2) &gt; 27%. Estos pacientes realizaron TE, en el que se analizaron: presi&#243;n arterial sist&#243;lica en el pico del esfuerzo (PAS P), frecuencia card&#237;aca en el pico del esfuerzo (FCP), variaci&#243;n de la presi&#243;n arterial sist&#243;lica intraesfuerzo (&#916; PAS), reserva cronotr&#243;pica y capacidad funcional en MET. Para el an&#225;lisis estad&#237;stico se utilizaron el test t de Student o el test U de Mann-Whitney, el coeficiente de Spearman y el coeficiente de regresi&#243;n lineal. RESULTADOS: La PAS P (G1: 181,00 &#177; 28,01; G2: 153,27 &#177; 27,71, p = 0,027), la &#916; PAS [G1: 64 (47,5-80,5); G2: 36 (25-47) mmHg, p = 0,015], la FCP (G1: 136,91 &#177; 19,66; G2: 118,45 &#177; 13,98 lpm, p = 0,018), la reserva cronotr&#243;pica (G1: 70,42 &#177; 17,94; G2: 49,47 &#177; 14,89%, p = 0,006) y la capacidad funcional [G1: 8,37 (6,47-10,27); G2: 4,42 (2,46-6,38) MET, p=0,003] fueron menores menores en el G2. Hubo una correlaci&#243;n negativa entre la tasa de Washout con PASP (r = -0,505, p = 0,014), &#916; PAS (r = -0,493, p = 0,017) y capacidad funcional (r = -0,646, p = 0,001). Despu&#233;s de la regresi&#243;n lineal, PASP (r = -0,422, p = 0,016) y capacidad funcional (r = -0,804, p = 0,004) se asociaron con la tasa de Washout. CONCLUSI&#211;N: En pacientes con insuficiencia card&#237;aca, la PASP y la capacidad funcional fueron las variables m&#225;s asociadas con la tasa de Washout. (Arq Bras Cardiol 2011;96(5):370-376)</p>
      </abstract>
      <kwd-group xml:lang="es">
        <kwd>MIBG</kwd>
        <kwd>prueba de esfuerzo</kwd>
        <kwd>insuficiencia card&#237;aca</kwd>
      </kwd-group>
    </front-stub>
    <body>
      <p>
        <bold>ART&#205;CULO ORIGINAL</bold>
      </p>
      <p>
        <fn id="topo-body3">
          <label>
            <bold>Relaci&#243;n entre imagen adren&#233;rgica card&#237;aca y ergometr&#237;a en la insuficiencia card&#237;aca</bold>
          </label>
          <p>
            <bold>Leandro Rocha Messias<sup>I</sup>; Maria &#194;ngela M. de Queiroz Carreira<sup>I</sup>; Sandra Marina Ribeiro de Miranda<sup>I</sup>; Jader Cunha de Azevedo<sup>I,2</sup>; Isabela Ambr&#243;sio Gava<sup>I</sup>; Ronaldo Campos Rodrigues<sup>I</sup>; Elizabeth Mar&#243;stica<sup>I</sup>; Ant&#244;nio Claudio Lucas da N&#243;brega<sup>I,II</sup>; Claudio Tinoco Mesquita<sup>I,II</sup></bold>
          </p>
        </fn>
      </p>
      <p><sup>I</sup>Universidade Federal Fluminense, Niter&#243;i, RJ</p>
      <p><sup>II</sup>Hospital Procard&#237;aco, Rio de Janeiro, RJ - Brasil</p>
      <p>Correspondencia</p>
      <p>
        <bold>RESUMEN</bold>
      </p>
      <p><bold>FUNDAMENTOS:</bold> En la Insuficiencia Card&#237;aca, la Ergometr&#237;a (Test Ergom&#233;trico - TE) eval&#250;a la capacidad funcional, un determinante de pron&#243;stico. El centellograma con I&#185;&#178;&#179; MIBG muestra la activaci&#243;n simp&#225;tica card&#237;aca.</p>
      <p><bold>OBJETIVO:</bold> Evaluar la asociaci&#243;n entre las variables del TE y las alteraciones del centellograma con I&#185;&#178;&#179; MIBG.</p>
      <p><bold>M&#201;TODOS:</bold> Se sometieron 23 pacientes (FEVI <underline>&lt;</underline> 45%) a centellograma con I&#185;&#178;&#179; MIBG y se separaron en: G1) tasa de <italic>Washout</italic> &lt; 27%; G2) <underline>&gt;</underline> 27%. Estos pacientes realizaron TE, en el que se analizaron: presi&#243;n arterial sist&#243;lica en el pico del esfuerzo (PAS P), frecuencia card&#237;aca en el pico del esfuerzo (FCP), variaci&#243;n de la presi&#243;n arterial sist&#243;lica intraesfuerzo (&#916; PAS), reserva cronotr&#243;pica y capacidad funcional en MET. Para el an&#225;lisis estad&#237;stico se utilizaron el test t de <italic>Student</italic> o el test U de <italic>Mann-Whitney</italic>, el coeficiente de <italic>Spearman</italic> y el coeficiente de regresi&#243;n lineal.</p>
      <p><bold>RESULTADOS:</bold> La PAS P (G1: 181,00 &#177; 28,01; G2: 153,27 &#177; 27,71, p = 0,027), la &#916; PAS [G1: 64 (47,5-80,5); G2: 36 (25-47) mmHg, p = 0,015], la FCP (G1: 136,91 &#177; 19,66; G2: 118,45 &#177; 13,98 lpm, p = 0,018), la reserva cronotr&#243;pica (G1: 70,42 &#177; 17,94; G2: 49,47 &#177; 14,89%, p = 0,006) y la capacidad funcional [G1: 8,37 (6,47-10,27); G2: 4,42 (2,46-6,38) MET, p=0,003] fueron menores menores en el G2. Hubo una correlaci&#243;n negativa entre la tasa de <italic>Washout</italic> con PASP (r = -0,505, p = 0,014), &#916; PAS (r = -0,493, p = 0,017) y capacidad funcional (r = -0,646, p = 0,001). Despu&#233;s de la regresi&#243;n lineal, PASP (r = -0,422, p = 0,016) y capacidad funcional (r = -0,804, p = 0,004) se asociaron con la tasa de <italic>Washout</italic>.</p>
      <p><bold>CONCLUSI&#211;N:</bold> En pacientes con insuficiencia card&#237;aca, la PASP y la capacidad funcional fueron las variables m&#225;s asociadas con la tasa de <italic>Washout</italic>. (Arq Bras Cardiol 2011;96(5):370-376)</p>
      <p><bold>Palabras clave:</bold> MIBG, prueba de esfuerzo, insuficiencia card&#237;aca.</p>
      <p>
        <bold>Introducci&#243;n</bold>
      </p>
      <p>En la insuficiencia card&#237;aca (IC), el test ergom&#233;trico (TE) es indicado para evaluar la capacidad funcional, presencia de s&#237;ntomas y la terap&#233;utica<sup>1</sup>. Algunos de los par&#225;metros empleados en el TE son el comportamiento de la presi&#243;n arterial sist&#243;lica (PAS) intraesfuerzo y la reserva cronotr&#243;pica, que son reconocidos predictores de pron&#243;stico<sup>2-4</sup>. La hiperactividad adren&#233;rgica, caracter&#237;stica de la IC, puede conducir a incompetencia cronotr&#243;pica, a la disminuci&#243;n de la respuesta contr&#225;ctil card&#237;aca a las catecolaminas, y a la disminuci&#243;n de la reserva simp&#225;tica durante el ejercicio. Una inadecuada respuesta de la PAS y de la frecuencia card&#237;aca (FC) se ha asociado a un riesgo dos veces mayor de mortalidad y eventos cardiovasculares adversos<sup>2,5-7</sup>. Tanto para la poblaci&#243;n general<sup>8</sup>, como para la poblaci&#243;n con IC<sup>2,9</sup>, la capacidad funcional es un importante predictor de pron&#243;stico y no est&#225; relacionada con medidas de la funci&#243;n ventricular en reposo y tampoco con la fracci&#243;n de eyecci&#243;n ventricular izquierda<sup>10</sup>.</p>
      <p>La actividad y la inervaci&#243;n simp&#225;tica card&#237;aca pueden evaluarse por centellograma con meta-yodo bencil guanidina marcada con yodo 123 (I<sup>123</sup> MIBG)<sup>11-13</sup>. Estudios han demostrado<sup>13-16</sup> que la imagen precoz representa la integridad de los terminales nerviosos presin&#225;pticos y la densidad de los beta receptores. La captaci&#243;n neuronal presin&#225;ptica contribuye para la imagen tard&#237;a, combinando informaciones de la funci&#243;n neural, incluyendo captaci&#243;n, liberaci&#243;n y almacenamiento de la noradrenalina en las ves&#237;culas presin&#225;pticas. La tasa de <italic>Washout</italic> es un par&#225;metro que eval&#250;a el grado de actividad simp&#225;tica. Pacientes con IC pueden presentar: (1) reducida captaci&#243;n del trazador debido a la p&#233;rdida de neuronas simp&#225;ticas y/o disturbios en la captaci&#243;n primaria de noradrenalina; y (2) aumento de la tasa de Washout, reflejando el desborde de noradrenalina para la corriente sangu&#237;nea<sup>11,14,17-19</sup>. Una tasa de <italic>Washout</italic> inferior al 27% es descriptor de fuerte predictor de sobrevida<sup>20</sup>.</p>
      <p>Hasta el momento, no hay evidencias de si la hiperactivaci&#243;n adren&#233;rgica en reposo se asocia con alteraciones hemodin&#225;micas en el ejercicio, o si las variables del TE se asocian con las variables del centellograma. Por lo tanto, el objetivo de este estudio es evaluar si las variables del TE convencional en la IC pueden detectar pacientes que presentan disfunci&#243;n simp&#225;tica en el centellograma con I<sup>123 </sup>MIBG. Estos hallazgos podr&#237;an permitir la evaluaci&#243;n del riesgo con una t&#233;cnica m&#225;s disponible en nuestro medio, seleccionando los pacientes con mayor probabilidad de presentar alteraciones en el centellograma.</p>
      <p>
        <bold>M&#233;todos</bold>
      </p>
      <p>Se seleccionaron 23 pacientes consecutivos atendidos en el ambulatorio especializado en IC del Hospital Universitario Ant&#244;nio Pedro, de la Universidad Federal Fluminense. Los pacientes seleccionados presentaban IC y fracci&#243;n de eyecci&#243;n ventricular izquierda menor o igual al 45%, medida por ecocardiograf&#237;a por la t&#233;cnica de Simpson. Se excluyeron del estudio los pacientes que presentaban: fibrilaci&#243;n atrial, diab&#233;ticos, portadores de dispositivo de estimulaci&#243;n ventricular, endocrinopat&#237;as, enfermedad de Parkinson, mujeres embarazadas o en per&#237;odo de lactancia. No se suspendi&#243; ninguna medicaci&#243;n para la realizaci&#243;n del estudio y todos se encontraban en tratamiento con dosis optimizadas de los medicamentos est&#225;ndar para IC, incluyendo el uso de betabloqueador (carvedilol). Los voluntarios firmaron un t&#233;rmino de consentimiento libre e informado, concordando en formar parte del proyecto. El proyecto fue aprobado por el comit&#233; de &#233;tica en investigaci&#243;n del Hospital Universitario Ant&#244;nio Pedro, con el n&#250;mero 011/09. </p>
      <p>Los pacientes realizaron TE limitada por s&#237;ntomas (<italic>software </italic>ErgoPC 13 versi&#243;n 2.2) en cinta, marca Imbramed, debidamente calibrada seg&#250;n las orientaciones del fabricante, en protocolo de Rampa. Se evaluaron el comportamiento de la PAS, de la FC intraesfuerzo y la capacidad funcional. La medida de la presi&#243;n arterial se realiz&#243; por m&#233;todo indirecto con utilizaci&#243;n de esfigmoman&#243;metro con columna de mercurio, debidamente calibrado, medido en el brazo izquierdo de los pacientes en posici&#243;n ortost&#225;tica. La medida de la frecuencia card&#237;aca se realiz&#243; mediante el intervalo RR del trazado del ECG a trav&#233;s del propio <italic>software</italic>. Se evaluaron la PAS y la FC en el pico del esfuerzo, la variaci&#243;n de la PAS en el pico del esfuerzo con relaci&#243;n al reposo (&#916; PAS), el &#237;ndice de reserva cronotr&#243;pica, mediante la f&#243;rmula: (<italic>"{[FC en el pico del esfuerzo - FC de reposo / (220 - Edad) - FC de reposo] x 100}")</italic><sup>4</sup>. La capacidad funcional se estim&#243; por el <italic>software</italic> de acuerdo con la carga de trabajo alcanzada.</p>
      <p>Los pacientes realizaron el centellograma mioc&#225;rdico con I&#185;&#178;&#179; MIBG, para evaluar la inervaci&#243;n adren&#233;rgica card&#237;aca, a trav&#233;s de la captaci&#243;n del radiotrazador, con estudio de la relaci&#243;n coraz&#243;n/mediastino (C/M) para las im&#225;genes precoces (30 minutos) y tard&#237;as (4 horas), adem&#225;s del c&#225;lculo de la tasa de <italic>Washout </italic>{<italic>[(C/M precoz - C/M tard&#237;a) / (C/M precoz)] x 100}</italic><sup>11</sup>. Todos los ex&#225;menes centellogr&#225;ficos se realizaron en el Servicio de Medicina Nuclear del Hospital Pr&#243;-Card&#237;aco de Rio de Janeiro, en c&#225;mara de centelleo tipo <italic>Anger</italic> tomogr&#225;fica digital (<italic>Single Photon Emission Computed Tomography</italic>) marca <italic>Siemens</italic>, modelo <italic>E-Cam</italic> de detector doble, con colimador de baja energ&#237;a y alta resoluci&#243;n. </p>
      <p>Los pacientes se dividieron en dos grupos de acuerdo con la tasa de <italic>Washout</italic>: Grupo 1 (G1), tasa de <italic>Washout</italic> &lt; 27% (normal); Grupo 2 (G2), tasa de <italic>Washout</italic> <underline>&gt;</underline> 27% (alterado)<sup>21</sup>. Para el an&#225;lisis estad&#237;stico, se utiliz&#243; el <italic>software</italic> SPSS versi&#243;n 15. Para evaluaci&#243;n de las variables cualitativas se utiliz&#243; el test chi-cuadrado. Para evaluaci&#243;n de las variables cuantitativas se utiliz&#243; el test t de Student o test <italic>U</italic> de <italic>Mann-Withney</italic>, conforme a la distribuci&#243;n de los datos. Se utiliz&#243; el coeficiente de correlaci&#243;n de <italic>Spearman</italic> para evaluar la correlaci&#243;n de las variables del ejercicio con la WO. Empleamos la regresi&#243;n lineal <italic>stepwise</italic> para identificar las variables asociadas con hiperton&#237;a simp&#225;tica evaluada por la tasa de <italic>Washout</italic>. Se consider&#243; con significancia estad&#237;stica el valor de p &lt; 0,05.</p>
      <p>
        <bold>Resultados</bold>
      </p>
      <p>Las caracter&#237;sticas de los pacientes se muestran en la <xref ref-type="table" rid="t1-body3">Tabla 1</xref>. No hubo diferencias significativas en la edad, sexo, &#237;ndice de masa corporal, etiolog&#237;a de la IC, fracci&#243;n de eyecci&#243;n ventricular izquierda, uso de medicaciones y dosis de carvedilol, entre los grupos.</p>
      <table-wrap id="t1-body3">
        <graphic xlink:href="1678-4170-abc-96-05-0370-00044-gt01-es.jpg"/></table-wrap>
      <p>Los grupos se muestran similares en reposo. En el pico de esfuerzo, hubo una diferencia significativa entre el G1 y el G2,, siendo que este &#250;ltimo present&#243; menores valores absolutos de PAS y de la FC, menor variaci&#243;n de la PAS intraesfuerzo, menor &#237;ndice de reserva cronotr&#243;pica y una menor capacidad funcional. Los par&#225;metros del ejercicio se muestran en la <xref ref-type="table" rid="t2-body3">Tabla 2</xref>, y la <xref ref-type="fig" rid="f1-body3">Figura 1</xref> presenta las diferencias en el comportamiento de la PAS durante el esfuerzo.</p>
      <table-wrap id="t2-body3">
        <graphic xlink:href="1678-4170-abc-96-05-0370-00044-gt02-es.jpg"/></table-wrap>
      <fig id="f1-body3">
        <graphic xlink:href="1678-4170-abc-96-05-0370-00044-gf01-es.jpg"/></fig>
      <p>A pesar de estar divididos por la tasa de <italic>Washout</italic>, no hubo diferencia significativa en la relaci&#243;n C/M precoz de I<sup>123</sup> MIBG (G1: 1,78 &#177; 0,25 <italic>vs</italic> G2: 1,74 &#177; 0,22; p = 0,710) y en la relaci&#243;n C/M tard&#237;a (G1: 1,74 &#177; 0,20 <italic>vs</italic> G2: 1,60 &#177; 0,22; p = 0,129). La <xref ref-type="fig" rid="esa04f2-body3">Figura 2</xref> ilustra la imagen card&#237;aca con I<sup>123 </sup>MIBG de un paciente con IC que presenta par&#225;metros de ejercicio normales (capacidad funcional de 8,23 MET, variaci&#243;n de laPAS intraesfuerzo de 65 mmHg e &#237;ndice de reserva cronotr&#243;pica del 68%). La captaci&#243;n del MIBG fue normal y la tasa de <italic>Washout</italic> fue del 21%.</p>
      <p content-type="asset">
        <fig id="esa04f2-body3">
          <graphic xlink:href="1678-4170-abc-96-05-0370-00044-gf02-es.jpg"/></fig>
      </p>
      <p>Cuando analizamos la correlaci&#243;n entre las variables del ejercicio y la tasa de <italic>Washout</italic>, observamos una correlaci&#243;n negativa significativa entre la tasa de <italic>Washout</italic> y las siguientes variables: PAS en el pico del esfuerzo, variaci&#243;n de la PAS intraesfuerzo y la CF (<xref ref-type="table" rid="t3-body3">Tabla 3</xref>). No se observ&#243; significancia estad&#237;stica en la correlaci&#243;n con la FC en el pico del esfuerzo y del &#237;ndice de reserva cronotr&#243;pica con WO (<xref ref-type="table" rid="t3-body3">Tabla 3</xref>).</p>
      <table-wrap id="t3-body3">
        <graphic xlink:href="1678-4170-abc-96-05-0370-00044-gt03-es.jpg"/></table-wrap>
      <p>Despu&#233;s de la regresi&#243;n lineal <italic>stepwise</italic>, las variables asociadas con disautonom&#237;a por la tasa de <italic>Washout</italic> fueron: la PAS en el pico del esfuerzo (<italic>r </italic>= -0,422; p = 0,016) y la capacidad funcional en MET (<italic>r</italic> = -0,804; p = 0,004).</p>
      <p>
        <bold>Discusi&#243;n</bold>
      </p>
      <p>En nuestro estudio observamos que en pacientes con IC, la PAS en el pico del esfuerzo y la capacidad funcional, medida a trav&#233;s del n&#250;mero de MET alcanzado, est&#225;n asociadas a alteraciones en la inervaci&#243;n adren&#233;rgica card&#237;aca, conforme fuera evidenciado por la tasa de Washout obtenida mediante centellograma mioc&#225;rdico con I<sup>123</sup> MIBG. Durante el TE, en los pacientes con tasa de <italic>Washout</italic> alterada (estado de hiperton&#237;a adren&#233;rgica en reposo), verificamos que la PAS en el pico del esfuerzo y el n&#250;mero de MET presentaron menores valores al compararlos con los de los pacientes con tasa de <italic>Washout</italic> normal. No hay, hasta el presente momento, descripci&#243;n en la bibliograf&#237;a de esta asociaci&#243;n entre tal comportamiento anormal de la PAS y alteraciones en la inervaci&#243;n adren&#233;rgica card&#237;aca por el I<sup>123</sup> MIBG.</p>
      <p>La variaci&#243;n de la PAS durante el ejercicio se asocia directamente con el d&#233;bito card&#237;aco durante el esfuerzo: una menor elevaci&#243;n de la PAS intraesfuerzo puede ser resultado de d&#233;ficit inotr&#243;pico durante el ejercicio, que es un fen&#243;meno com&#250;n en pacientes con disfunci&#243;n ventricular, estando este hallazgo asociado a un peor pron&#243;stico<sup>2</sup>. Fargard et al<sup>22</sup>, en una muestra de pacientes candidatos a trasplante card&#237;aco, demostraron que una variaci&#243;n inadecuada de la PAS en respuesta al ejercicio subm&#225;ximo es predictora de eventos card&#237;acos. </p>
      <p>Willians et al<sup>23</sup> evaluaron pacientes con IC de diferentes clases funcionales, demostrando que par&#225;metros simples obtenidos en el test, como la duraci&#243;n y la PAS pico del esfuerzo, son fuertes predictores de pron&#243;stico mediante an&#225;lisis multivariado, superando la fracci&#243;n de eyecci&#243;n ventricular izquierda y fracci&#243;n N terminal proBNP (NT-proBNP). </p>
      <p>Nishiyama et al<sup>2</sup> evaluaron la respuesta de la PAS durante el ejercicio como predictor de pron&#243;stico en pacientes con IC. Por an&#225;lisis univariado, PAS y FC en el pico del esfuerzo, adem&#225;s de sus variaciones durante el ejercicio (&#916; PAS/&#916; FC = pico del esfuerzo - reposo) fueron predictores de mortalidad. En este estudio, el grupo no sobreviviente present&#243; menores valores de tales variables. Despu&#233;s del an&#225;lisis multivariado, el &#916; PAS y la capacidad funcional, obtenida a trav&#233;s del n&#250;mero de MET alcanzado, fueron los mejores predictores de mortalidad, independiente del uso de betabloqueante. </p>
      <p>El consumo de ox&#237;geno (VO<sub>2</sub>) m&#225;ximo es un par&#225;metro utilizado para evaluar, en pacientes con IC, candidatos al trasplante card&#237;aco<sup>24</sup>, siendo tambi&#233;n un poderoso predictor de pron&#243;stico<sup>24-26</sup>. Willens et al<sup>27</sup>, estudiando 40 pacientes con IC, clase funcional II y III de la <italic>New York Heart Association </italic>(NYHA), demostraron que el VO<sub>2</sub> m&#225;ximo, tanto por medida indirecta (de acuerdo con el tiempo del ejercicio), como por medida directa, a trav&#233;s de la Prueba Cardiopulmonar del Ejercicio, es un importante predictor de sobrevida, ofreciendo informaciones &#250;tiles para el seguimiento de los pacientes. Otra forma de evaluar el VO<sub>2</sub> m&#225;ximo por medida indirecta es a trav&#233;s del n&#250;mero de MET alcanzado en el TE<sup>2</sup>.</p>
      <p>En un estudio involucrando individuos saludables, Snader et al<sup>8</sup> demostraron que la capacidad funcional fue un poderoso predictor de mortalidad cardiovascular. En este trabajo, la tasa de mortalidad cardiovascular fue mayor en el grupo que no consigui&#243; alcanzar 06 MET en el TE, y su asociaci&#243;n con defectos diagnosticados en la perfusi&#243;n por el centellograma mioc&#225;rdico con talio, coloc&#243; a estos pacientes en un nivel de riesgo aun mayor para eventos adversos.</p>
      <p>Jeng et al<sup>28</sup> evaluaron la influencia de la tolerancia al ejercicio sobre la calidad de vida en pacientes con IC. Los pacientes que obtuvieron una capacidad funcional mayor o igual a 05 MET, o un tiempo de TE mayor o igual a 180 segundos, presentaban una mejor calidad de vida, mostrando que el TE es seguro, disponible y efectivo para evaluar la tolerancia al ejercicio en esta poblaci&#243;n. Rubim et al<sup>29</sup> demostraron que el n&#250;mero de MET alcanzado en el TE se correlaciona significativamente con la mortalidad. </p>
      <p>Myers et al<sup>30</sup>, evaluando scores de calidad de vida, test de caminata de 06 minutos y n&#250;meros de MET alcanzado en el TE en pacientes con IC, y correlacionando estas variables con VO<sub>2</sub> m&#225;ximo obtenido a trav&#233;s de la Prueba Cardiopulmonar del Ejercicio, concluyeron que ambos reflejan, a su manera, el estado cl&#237;nico del pacientes y tienen su importancia en este contexto cl&#237;nico, sin, no obstante, que uno sustituya al otro. Cuando se compara con la distancia recorrida en el test de caminata de 06 minutos, la capacidad funcional determinada por el n&#250;mero de MET en el TE se correlacion&#243; significativamente mejor con el VO<sub>2</sub> m&#225;ximo obtenido por medida directa. </p>
      <p>Chandrashekhar et al<sup>31</sup> analizaron la capacidad de las variables com&#250;nmente empleadas en el TE en predecir el VO<sub>2</sub> m&#225;ximo. Despu&#233;s del an&#225;lisis de regresi&#243;n <italic>stepwise</italic>, el mejor predictor del VO<sub>2</sub> m&#225;ximo fue el n&#250;mero de MET alcanzado. A pesar de afirmar los autores que el n&#250;mero de MET no tenga una precisi&#243;n elevada, aun as&#237; es mejor predictor cl&#237;nico que las otras variables obtenidas, como por ejemplo, el comportamiento de la FC durante el esfuerzo. </p>
      <p>Una de las modificaciones m&#225;s significativas en el tratamiento de la insuficiencia card&#237;aca fue la introducci&#243;n de los betabloqueantes. Parikh et al<sup>32</sup>, en pacientes con IC, clase funcional del NYHA III y IV, evaluaron el efecto del betabloqueante metoprolol sobre el n&#250;mero de MET alcanzado en el TE, concluyendo que la optimizaci&#243;n del betabloqueante mejora el desempe&#241;o en el ejercicio, evaluado tanto por el tiempo de ejercicio, como por el n&#250;mero de MET.</p>
      <p>Algunos estudios sugieren que la mejora, que no es universalmente observada, puede ser, en parte, oriunda de la mejora de la funci&#243;n endotelial, debido al uso de los betabloqueantes asociado con inhibidor de la enzima convertidora de angiotensina<sup>33</sup>.</p>
      <p>Otra vertiente de marcadores de riesgo en la IC es a trav&#233;s de la imagen neuronal. El centellograma con I<sup>123 </sup>MIBG fue validado como marcador de pron&#243;stico, seg&#250;n meta-an&#225;lisis con 1.755 pacientes, publicado por Verbene et al<sup>19</sup>, que demostr&#243; que una reducci&#243;n de la relaci&#243;n C/M en la imagen tard&#237;a o aumento de la tasa de <italic>Washout</italic> en el centellograma mioc&#225;rdico con I<sup>123</sup> MIBG se asocia a un peor pron&#243;stico, al compararlo con pacientes que presentan normalidad de estos par&#225;metros. En una publicaci&#243;n reciente, Jacobson et al<sup>34</sup>, en un estudio multic&#233;ntrico con pacientes con clase funcional II y III del NYHA y fracci&#243;n de eyecci&#243;n ventricular izquierda inferior al 35%, demostraron que la evaluaci&#243;n adren&#233;rgica directa del coraz&#243;n, a trav&#233;s de centellograma mioc&#225;rdico con I<sup>123</sup> MIBG, fue predictora de mayor mortalidad card&#237;aca y de eventos arr&#237;tmicos, de modo independiente de factores pron&#243;sticos conocidos como la fracci&#243;n de eyecci&#243;n ventricular izquierda, p&#233;ptido natriur&#233;tico cerebral y de la clase funcional del NYHA. </p>
      <p>Analizando las informaciones funcionales obtenidas por la imagen neuronal con las de la Prueba Cardiopulmonar del Ejercicio, Cohen-Solal et al<sup>14</sup> correlacionaron el VO<sub>2</sub> m&#225;ximo con la captaci&#243;n de I<sup>123</sup> MIBG y diversas otras variables (fracci&#243;n de eyecci&#243;n ventricular izquierda, par&#225;metros hemodin&#225;micos, como &#237;ndice card&#237;aco y presi&#243;n capilar pulmonar). Observaron una correlaci&#243;n significativa entre los hallazgos centellogr&#225;ficos adren&#233;rgicos en el I<sup>123 </sup>MIBG y el VO<sub>2</sub> m&#225;ximo en el ejercicio. Analizando sus desenlaces (muerte cardiovascular y trasplante card&#237;aco), el mayor determinante de pron&#243;stico fue el VO<sub>2</sub> m&#225;ximo. El VO<sub>2 </sub>m&#225;ximo se correlacion&#243; mejor con la relaci&#243;n C/M para imagen tard&#237;a que con la relaci&#243;n C/M para imagen precoz y con la tasa de <italic>Washout</italic>. En contrapartida, nuestro estudio encontr&#243; una mayor correlaci&#243;n de la tasa de <italic>Washout</italic> con el n&#250;mero de MET alcanzado, y no con la relaci&#243;n C/M tard&#237;a, como en el estudio de Cohen-Solal et al<sup>14</sup>.</p>
      <p>Mientras tanto, existen significativas diferencias entre los estudios: en nuestra casu&#237;stica, evaluamos el VO<sub>2</sub> m&#225;ximo por medida indirecta a trav&#233;s del n&#250;mero de METs alcanzados, mientras que Cohen-Solal et al utilizaron medida directa del VO<sub>2</sub>. En el estudio de Cohen-Solal et al<sup>14</sup>, solamente 13 % de los pacientes estaban usando betabloqueantes, mientras que en el nuestro todos los pacientes estaban en uso de esta medicaci&#243;n. Los betabloqueantes tienen como una de sus acciones la resensibilizaci&#243;n de los beta receptores, lo que puede influir en la relaci&#243;n C/M, hecho que explicar&#237;a las divergencias de los hallazgos<sup>5,35</sup>.</p>
      <p>
        <bold>Limitaciones del estudio</bold>
      </p>
      <p>La principal limitaci&#243;n del estudio fue el n&#250;mero reducido de pacientes. No obstante, en un estudio piloto con 16 pacientes, se realiz&#243; un c&#225;lculo muestral y el n&#250;mero de 23 pacientes tiene un poder estad&#237;stico del 90% para identificar el 50% de diferencia en la capacidad funcional y un poder estad&#237;stico del 80% para identificar el 50% de diferencia en la PAS en el pico del esfuerzo.</p>
      <p>Otra limitaci&#243;n significativa fue el haber empleado en la capacidad funcional el n&#250;mero de MET alcanzado, y no el VO<sub>2</sub> m&#225;ximo calculado directamente a trav&#233;s de la Prueba Cardiopulmonar del Ejercicio, pues no dispon&#237;amos del equipamiento necesario en nuestra instituci&#243;n al momento de la realizaci&#243;n de este estudio. No obstante, como el TE es una herramienta simple y ampliamente presente en nuestro medio, creemos que las informaciones derivadas de este examen puedan ser &#250;tiles para los cardi&#243;logos involucrados con la pr&#225;ctica cl&#237;nica en pacientes con IC, puesto que se correlacionaron con el sofisticado an&#225;lisis de la inervaci&#243;n card&#237;aca. Otra variable importante observada como significativa en nuestro estudio, que fue la PAS en el pico del esfuerzo, tambi&#233;n se deriva del TE y no requiere complejas metodolog&#237;as para an&#225;lisis.</p>
      <p>
        <bold>Conclusi&#243;n</bold>
      </p>
      <p>Los pacientes con IC y tasa de <italic>Washout</italic> alterada en el centellograma mioc&#225;rdico con I<sup>123</sup> MIBG presentaron menor respuesta inotr&#243;pica, cronotr&#243;pica y una menor capacidad funcional. La PAS en el pico del esfuerzo y el n&#250;mero de MET alcanzados fueron las variables del TE que m&#225;s se asociaron con esta hiperton&#237;a adren&#233;rgica evaluada por el centellograma. El TE convencional, a trav&#233;s de la evaluaci&#243;n de esas dos variables, puede utilizarse como una forma de prever la presencia de hiperactividad adren&#233;rgica card&#237;aca en paciente con IC. </p>
      <p>
        <bold>Agradecimiento</bold>
      </p>
      <p>Agradecimiento a la FAPERJ y al CNPq por el apoyo a los proyectos de investigaci&#243;n de la <italic>Universidade Federal Fluminense</italic>.</p>
      <p>
        <bold>Potencial Conflicto de Intereses</bold>
      </p>
      <p>Declaro no haber conflicto de intereses pertinentes.</p>
      <p>
        <bold>Fuentes de Financiaci&#243;n</bold>
      </p>
      <p>El presente estudio no tuve fuentes de financiaci&#243;n externas.</p>
      <p>
        <bold>Vinculaci&#243;n Acad&#233;mica</bold>
      </p>
      <p>Este art&#237;culo forma parte de Disertaci&#243;n de Maestr&#237;a de Leandro Rocha Messias, por la Universidad Federal Fluminense.</p>
      <p>
        <bold>Referencias</bold>
      </p>
    </body>
  </sub-article>
</article>
